d-alpha tocopherol has been researched along with Cancer of Prostate in 364 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (1.65) | 18.7374 |
| 1990's | 29 (7.97) | 18.2507 |
| 2000's | 191 (52.47) | 29.6817 |
| 2010's | 125 (34.34) | 24.3611 |
| 2020's | 13 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, HC; Koshino, H; Yoo, ID; Yu, SH; Yun, BS | 1 |
| Albanes, D; Huang, J; Lim, JE; Mӓnnistӧ, S; Weinstein, SJ | 1 |
| Albanes, D; Huang, J; Lawrence, WR; Lim, JE; Mӓnnistӧ, S; Weinstein, SJ | 1 |
| Chia, SE; Kishida, R; Loh, WQ; Ong, CN; Seow, WJ; Yin, X | 1 |
| Albanes, D; Hada, M; Mondul, AM; Weinstein, SJ | 1 |
| Carpi, A; Ferrari, P; Morganti, R; Nicolini, A | 1 |
| Asay, S; Barnes, B; Graham, A; Hollingsworth, S; Kenealey, JD; Michaelis, DJ; Oblad, RV | 1 |
| Krishnan, K; Lightner, J; Mahboob, R; Moore, C; Palau, VE; Stone, W | 1 |
| Goodin, S; Kim, I; Lee, MJ; Orlick, M; Shih, WJ; Yang, CS; Zheng, X | 1 |
| Beninati, S; Borromeo, I; De Martino, A; Elia, AC; Feriotto, G; Forni, C; Magara, G; Mischiati, C; Tabolacci, C; Torricelli, P | 1 |
| Albanes, D; Derkach, A; Huang, J; Mondul, AM; Moore, SC; Sampson, JN; Weinstein, SJ | 1 |
| Kaneko, S; Kato, K; Kohno, K; Sato, A; Yamazaki, T; Yano, T | 1 |
| Albanes, D; Virtamo, J; Weinstein, SJ | 1 |
| Chun, OK; Fontham, ET; Koo, SI; Su, J; Vance, TM | 1 |
| Bauer, SR; Carroll, PR; Chan, JM; Richman, EL; Song, X; Sosa, E; Weinberg, V; Witte, JS | 1 |
| Bellezza, I; Gatticchi, L; Grottelli, S; Mierla, AL; Minelli, A | 1 |
| Cui, R; Liu, ZQ; Xu, Q | 1 |
| Albanes, D; Karoly, ED; Mondul, AM; Moore, SC; Sampson, JN; Weinstein, SJ | 1 |
| Albanes, D; Alberg, AJ; Allen, NE; Appleby, PN; Barricarte, A; Black, A; Boeing, H; Bueno-de-Mesquita, HB; Chan, JM; Chen, C; Cook, MB; Donovan, JL; Galan, P; Gilbert, R; Giles, GG; Giovannucci, E; Goodman, GE; Goodman, PJ; Gunter, MJ; Hamdy, FC; Heliövaara, M; Helzlsouer, KJ; Henderson, BE; Hercberg, S; Hoffman-Bolton, J; Hoover, RN; Johansson, M; Key, TJ; Khaw, KT; King, IB; Knekt, P; Kolonel, LN; Le Marchand, L; Männistö, S; Martin, RM; Meyer, HE; Mondul, AM; Moy, KA; Neal, DE; Neuhouser, ML; Palli, D; Platz, EA; Pouchieu, C; Rissanen, H; Schenk, JM; Severi, G; Stampfer, MJ; Tjønneland, A; Touvier, M; Travis, RC; Trichopoulou, A; Weinstein, SJ; Zhou, CK; Ziegler, RG | 1 |
| Fajardo, AM; MacKenzie, DA; Olguin, SL; Rabinowitz, I; Scariano, JK; Thompson, TA | 1 |
| Alberts, DS; Darke, AK; Fales, L; Goodman, PJ; Jacobs, ET; Lance, P; Minasian, L; Roe, DJ; San Jose, J; Thompson, IM; Thompson, PA; Wang, F; Yee, M | 1 |
| Cecchini, MG; Klima, I; Peternac, D; Schwaninger, R; Studer, UE; Thalmann, GN | 1 |
| Ahn, J; Albanes, D; Moslehi, R; Snyder, K; Virtamo, J; Weinstein, SJ | 1 |
| Agudo, A; Allen, NE; Appleby, PN; Barricarte, A; Bingham, S; Boeing, H; Boffetta, P; Bueno-de-Mesquita, HB; Grioni, S; Hallmans, G; Johnsen, NF; Kaaks, R; Key, TJ; Khaw, KT; Kiemeney, LA; Larrañaga, N; Linseisen, J; Misirli, G; Overvad, K; Palli, D; Riboli, E; Rinaldi, S; Roddam, AW; Rodriguez, L; Sacerdote, C; Sánchez, MJ; Slimani, N; Stattin, P; Tjønneland, A; Tormo, MJ; Trichopoulos, D; Trichopoulou, A; Tumino, R; Weikert, S | 1 |
| Belanger, C; Bubes, V; Buring, JE; Christen, WG; Gaziano, JM; Glynn, RJ; Kurth, T; MacFadyen, J; Manson, JE; Sesso, HD | 1 |
| Albanes, D; Arnold, KB; Baker, LH; Bearden, JD; Claudio, J; Coltman, CA; Cook, ED; Crawford, ED; Crowley, JJ; Darke, AK; Ford, LG; Ganz, PA; Gaziano, JM; Goodman, GE; Goodman, PJ; Hartline, JA; Jagpal, TJ; Karp, DD; Klein, EA; Kristal, AR; Lieber, MM; Lippman, SM; Lucia, MS; Meyskens, FL; Minasian, LM; Parnes, HL; Parsons, JK; Probstfield, JL; Santella, RM; Taylor, PR; Thompson, IM; Walther, P; Winquist, E | 1 |
| Chemler, SR; DiMaggio, MA; Haque, I; Huang, K; James, NS; Kasi, D; Mai, T; Ni, J; Pang, ST; Xie, S; Yeh, S | 1 |
| Albanes, D; Gunter, MJ; Lawson, KA; Moore, SC; Peters, U; Snyder, K; Virtamo, J; Weinstein, SJ; Wright, ME; Yeager, M | 1 |
| Klein, EA | 5 |
| Do, KA; Efstathiou, E; Kim, J; Lippman, SM; Logothetis, CJ; McDonnell, TJ; Menter, DG; Pettaway, CA; Pisters, LL; Stephens, C; Taylor, R; Thall, PF; Troncoso, P; Tsavachidou, D; Vakar-Lopez, F; Wang, X; Wen, S; Wood, CG | 1 |
| Block, KI | 1 |
| Albanes, D; Gail, MH; Virtamo, J; Watters, JL; Weinstein, SJ | 1 |
| Chen, CS; Chuang, HC; Huang, PH; Kulp, SK; Wang, D; Wei, S | 1 |
| Bosland, MC; Johnson, WD; Lubet, RA; McCormick, DL; Rao, KV; Steele, VE | 1 |
| Bosland, MC; Horton, L; Lasano, S; Ozten, N | 1 |
| Guerrieri, R; Neuzil, J; Santarelli, L; Staffolani, S; Strafella, E; Tomasetti, M | 1 |
| Arai, H; Atkinson, J; Barnholtz-Sloan, J; Danielpour, D; Klein, E; Manor, D; Morley, S; Parker, R; Thakur, V | 1 |
| Lentini, A; Provenzano, B; Ricci, P; Tabolacci, C; Torricelli, P | 1 |
| Albanes, D; Männistö, S; Mondul, AM; Snyder, K; Virtamo, J; Watters, JL; Weinstein, SJ | 1 |
| Albanes, D; Feinleib, M; Menke, A; Mondul, AM; Nelson, WG; Platz, EA; Rohrmann, S | 1 |
| Ambrosone, CB; Barnett, MJ; Cheng, TY; Goodman, GE; King, IB; Kristal, AR; Neuhouser, ML; Thornquist, MD | 1 |
| Albanes, D; Mondul, AM; Virtamo, J; Weinstein, SJ | 1 |
| Karppi, J; Kauhanen, J; Kurl, S; Laukkanen, JA | 1 |
| Bellezza, I; Galli, F; Grottelli, S; Mierla, AL; Minelli, A; Pilolli, F; Tucci, A | 1 |
| Abbruzzese, A; Beninati, S; Caraglia, M; Torricelli, P | 1 |
| Ahn, J; Albanes, D; Friesen, MD; Hayes, RB; Peters, U; Riboli, E; Weinstein, SJ | 1 |
| Albanes, D; Bosworth, T; Mondul, AM; Remaley, AT; Virtamo, J; Weinstein, SJ | 1 |
| Benzie, IF; Cheung, A; Leung, G; Tsao, SW; Wong, YC | 1 |
| Albanes, D; Paltoo, D; Tangrea, J; Taylor, P; Virtamo, J; Woodson, K | 1 |
| Chen, C; Goodman, GE; King, I; Omenn, GS; Schaffer, S | 1 |
| Albanes, D; Albert, P; Huttunen, JK; Korhonen, P; Malila, N; Pietinen, P; Taylor, PR; Virtamo, J; Virtanen, MJ | 1 |
| Albanes, D; Lehman, TA; Modali, R; Snyder, K; Tangrea, JA; Taylor, KM; Taylor, PR; Virtamo, J; Woodson, K | 1 |
| Azzi, A; Gysin, R; Kempná, P; Ricciarelli, R; Villacorta, L; Visarius, T; Zingg, JM | 1 |
| Albanes, D; Giovannucci, E; Männistö, S; Pietinen, P; Salminen, I; Virtamo, J; Virtanen, MJ | 1 |
| Azzi, A; Betti, M; Conte, C; Floridi, A; Galli, F; Pistilli, A; Rende, M; Stabile, AM | 1 |
| Kakizoe, T | 1 |
| Albanes, D; King, I; Pietinen, P; Tan, C; Taylor, PR; Virtamo, J; Weinstein, SJ; Wright, ME | 1 |
| Gaziano, JM; Giovannucci, E; Kantoff, PW; Leitzmann, MF; Li, H; Ma, J; Stampfer, MJ | 1 |
| Basler, JW; Fernandes, G; Hernáandez, J; Syed, S; Thompson, IM; Troyer, DA; von Merveldt, D; Weiss, G | 1 |
| Al Azab, R; Fleshner, N | 1 |
| Bostick, RM; Goodman, M; Mandel, JS; Taylor, JA; Terry, PD; van Gils, CH; Ward, KC | 1 |
| Albanes, D; Pietinen, P; Stolzenberg-Solomon, R; Taylor, PR; Virtamo, J; Weinstein, SJ | 1 |
| Albanes, D; McCarron, P; Pietinen, P; Sequoia, JS; Taylor, PR; Virtamo, J; Wright, ME | 1 |
| Ni, J; Pang, ST; Yeh, S | 1 |
| Campos, H; Giovannucci, EL; Holmes, MD; Powell, IJ; Stampfer, MJ; Willett, WC | 1 |
| Baniel, J; Gur, U; Lichtenberg, D; Neumann, A; Pinchuk, I; Yossepowitch, O | 1 |
| Albanes, D; Diaw, L; Faupel-Badger, JM; Tangrea, JA; Virtamo, J; Woodson, K | 1 |
| Jia, L; Kline, K; Li, J; Sanders, BG; Wang, P; Yu, W | 1 |
| Bagshaw, DM; Fishell, VK; Hartman, TJ; Kris-Etherton, PM; Lawrence, FR; Spaccarotella, KJ; Stone, WL; West, SG | 1 |
| McArdle, C; McMillan, DC; O'Reilly, DS; Sattar, N; Talwar, D; Underwood, M | 1 |
| Sun, Y; Wang, H; Yan, W; Yang, CS | 1 |
| Anselmi, M; Fontana, F; Limonta, P | 1 |
| Goodman, PJ; Lucia, MS; Neuhouser, ML; Schenk, JM; Tangen, CM; Thompson, IM; Till, C | 1 |
| Loh, WQ; Seow, WJ; Youn, J | 1 |
| Canistro, D; Cirillo, S; Croce, CMD; Filippi, S; Franchi, P; Longo, V; Lorenzini, A; Lucarini, M; Marchionni, S; Paolini, M; Papi, A; Rotondo, F; Spisni, E; Vivarelli, F; Vornoli, A; Zanzi, C | 1 |
| Audano, M; Beretta, G; Fontana, F; Limonta, P; Marzagalli, M; Mitro, N; Procacci, P; Raimondi, M; Sartori, P | 1 |
| Abdulkadir, SA; Anker, JF; McGee, WA; Naseem, AF; Njoroge, RN; Nonn, L; Unno, K; Zhao, JC | 1 |
| Kaneko, S; Namiki, K; Sato, A; Sato, C; Virgona, N; Yano, T | 1 |
| Alvarez-Cubero, MJ; López-Guarnido, O; Lorente, JA; Lozano-Paniagua, D; Pascual-Geler, M; Rivas, A; Rodrigo, L; Saiz, M; Urquiza-Salvat, N | 1 |
| Hantash, J | 1 |
| Kaneko, S; Sato, A; Sato, C; Sato, H; Shiozawa, N; Virgona, N; Yano, T | 1 |
| Burns, NA; Deardorff, OG; Hunter, DR | 1 |
| Jayaram, R; Thavarajah, M | 1 |
| Clements, JA; Ling, MT; Liu, J; Russell, PJ; Tang, KD | 1 |
| Brunner, KT; Henneberg, CJ; Long, MT; Wilechansky, RM | 1 |
| Elbayoumi, T; Yao, M | 1 |
| Chen, A; Guan, F; Ju, J; Li, G; Yang, CS; Yang, Z | 1 |
| Anderson, J; Kim, Y; Muruganandham, M; Pigge, FC; Schindel, J | 1 |
| Dunn, BK; Nicastro, HL | 1 |
| Nambiar, D; Singh, RP | 1 |
| Azzouzi, AR; Cancel-Tassin, G; Cussenot, O; Eisinger, F; Gravis, G; Rossi, D | 1 |
| Andriole, GL; Nepple, KG; Sandhu, GS; Tanagho, YS | 1 |
| Awan, M; Begum, A; Bhatti, S; Butt, G; Farooqi, AA; Mansoor, Q; Qadir, MI; Shaukat, U; Yousaf, G | 1 |
| Brasky, TM; Darke, AK; Goodman, GE; Goodman, PJ; Klein, EA; Kristal, AR; Meyskens, FL; Minasian, LM; Parnes, HL; Song, X; Tangen, CM; Thompson, IM | 1 |
| Hadjipavlou, M; Khan, S; Philippou, Y; Rane, A | 1 |
| Andriole, GL; Freedland, SJ; Hamilton, RJ; Vemana, G | 1 |
| Cabang, AB; Thompson, IM; Wargovich, MJ | 1 |
| Brawley, OW; Ford, LG; Minasian, LM; Parnes, HL | 1 |
| Darke, AK; Goodman, GE; Goodman, PJ; Klein, EA; Kristal, AR; Lippman, SM; Meyskens, FL; Minasian, LM; Morris, JS; Parnes, HL; Tangen, CM; Thompson, IM | 1 |
| Frankel, PH; Madsen, FC; Parker, RS; Whanger, PD | 1 |
| Payton, S | 1 |
| Guo, L; Sun, L; Wang, K; Xiong, W; Zheng, Y | 1 |
| Albanes, D; Berndt, SI; Chanock, S; Hyland, PL; Major, JM; Weinstein, SJ; Yeager, M; Yu, K | 1 |
| Goodman, GE; Goodman, PJ; Klein, EA; Kristal, AR; Meyskens, FL; Minasian, LM; Neuhauser, ML; Parnes, HL; Schenk, JM; Song, X; Tangen, CM; Thompson, IM; Till, C | 1 |
| Kristal, A; Platz, EA; Thompson, I | 1 |
| Abdulkadir, SA; Darke, AK; Fowke, JH; Goodman, PJ; Klein, EA; Martinez, EE; Tangen, CM | 1 |
| Heinzl, S | 1 |
| Bubes, V; Buring, JE; Christen, WG; Gaziano, JM; Glynn, RJ; Manson, JE; Sesso, HD; Wang, L | 1 |
| Schwartz, GG | 1 |
| Chen, J; Lau, EY; Lee, TK; Ling, MT; Liu, J; Lo, J; Ng, IO; Tang, KD; Yong, J | 1 |
| Bearden, JD; Blanke, CD; Christen, WG; Crowley, JJ; Darke, AK; Gaziano, JM; Glynn, RJ; Goodman, GE; Goodman, PJ; Klein, EA; Lad, TE; Lippman, SM; Minasian, LM; Thompson, IM | 1 |
| Kormos, W | 1 |
| Dueregger, A; Eder, IE; Heidegger, I; Klocker, H; Ofer, P; Perktold, B; Ramoner, R | 1 |
| Itharat, A; Makchuchit, S; Panthong, S; Rattarom, R; Sakpakdeejaroen, I; Uttama, S | 1 |
| Dunn, BK; Ghosh, S; Kramer, BS | 1 |
| Ramamoorthy, V; Rubens, M; Saxena, A; Shehadeh, N | 1 |
| Adams, DJ; Barui, AK; Kulhari, H; Naidu Vegi, GM; Patra, CR; Pooja, D; Shrivastava, S; Sistla, R; Telukutala, SR | 1 |
| Bin, H; Liang, W; Nan, W; Rui, T; Shuhai, Z; Wei, Z; Zhifang, M | 1 |
| Arnold, KB; Barrington, WE; Etzioni, R; Kristal, AR; Lucia, MS; Neuhouser, ML; Schenk, JM; Thompson, IM | 1 |
| Thomas, CR | 1 |
| Citronberg, J; Fedirko, V; Goodman, M; Hartman, T; Kim, Y; Wei, J | 1 |
| Sato, A; Sato, C; Shiozawa, S; Sugahara, R; Uchida, A; Virgona, N; Yano, T | 1 |
| Taneja, SS | 1 |
| Eickhoff, JC; Heath, EI; Kolesar, J; Kyriakopoulos, CE; Liu, G; Moll, T; Wilding, G; Yayehyirad, M | 1 |
| Auvinen, A; Määttänen, L; Murtola, TJ; Sarre, S; Tammela, TL | 1 |
| Li, L; Wang, J; Wang, Y; Xu, L; Xue, P; Zhou, J | 1 |
| Bosland, MC | 1 |
| Chan, JM; Darke, AK; Goodman, PJ; Kantoff, PW; Klein, EA; Lee, GM; Mucci, LA; Peisch, S; Penney, KL; Rae, JM; Sun, T; Tangen, CM; Thompson, IM; Tinianow, AM | 1 |
| Albanes, D; Mondul, AM; Weinstein, SJ | 1 |
| Anderson, K; Arnold, KB; Caban-Holt, A; Cassano, PA; Christen, WG; Crowley, JJ; Darke, AK; Goodman, PJ; Hartline, J; Klein, EA; Lance, P; Meyskens, FL; Minasian, LM; Tangen, CM; Yee, M | 1 |
| Ahmad, N; Ahsan, H; Mukhtar, H; Nihal, M; Reagan-Shaw, S | 1 |
| Bureyko, T; Clandinin, MT; Hurdle, H; Mazurak, VC; Metcalfe, JB | 1 |
| Chang, PN; Han, HY; Lee, DT; Ling, MT; Wong, YC; Yap, WN; Yap, YL | 1 |
| Gann, PH | 1 |
| Coogan, P; Palmer, JR; Rosenberg, L; Strom, BL; Zhang, Y | 1 |
| Albanes, D | 2 |
| Berndt, SI; Chanock, S; Chatterjee, N; Hayes, RB; Huang, WY; Kang, D; Lee, KM; Park, SK; Reding, D | 1 |
| Dunn, BK; Ford, LG; Ryan, A | 1 |
| Frei, B; Roberts, LJ; Traber, MG | 1 |
| Gladyshev, VN; Hatfield, DL | 1 |
| Fitzpatrick, JM; Schröder, FH; Schulman, C; Zlotta, AR | 1 |
| Simon, HB | 1 |
| Allen, NE; Key, TJ | 1 |
| Amling, CL; Colli, JL | 1 |
| El-Bayoumy, K | 1 |
| Fleshner, NE; Jacob, LE; Klotz, LH; Nam, RK; Ramani, M; Sugar, LM; Venkateswaran, V | 1 |
| Fairweather-Tait, S; Hurst, R | 1 |
| Combs, GF; Rayman, MP; Waters, DJ | 1 |
| Pinsky, PF | 1 |
| Bidoli, E; Bosetti, C; Franceschi, S; La Vecchia, C; Lenardon, O; Maso, LD; Montella, M; Negri, E; Polesel, J; Serraino, D; Talamini, R; Zucchetto, A | 1 |
| Hawk, ET; Lippman, SM | 1 |
| Schrauzer, GN | 1 |
| Lippman, SM; Platz, EA | 1 |
| Azzi, A; Zingg, JM | 1 |
| Buntinx, F; Goossens, ME; Zeegers, MP | 1 |
| Adaramoye, O; Akinloye, O; Kareem, O | 1 |
| Ling, MT; Ngoh, CP; Tan, YL; Wong, YC; Yap, WN; Yap, YL; Zaiden, N; Zhang, XW | 1 |
| Sakai, H | 1 |
| Constantinou, AI; Constantinou, C; Hadjivassiliou, V; Hyatt, JA; Neophytou, C; Papas, A; Papas, KA; Vraka, PS | 1 |
| Anderson, KB; Arnold, KB; Campbell, RD; Cook, ED; Hamilton, SJ; Hermos, JA; McCaskill-Stevens, W; Minasian, LM; Moody-Thomas, S; Probstfield, JL | 1 |
| Dearnaley, DP; Grace, P; Horwich, A; Huddart, RA; Parker, CC; Thomas, K; Venkitaraman, R | 1 |
| Lee, DT; Ling, MT; Luk, SY; Wong, YC; Yap, WN; Yap, YL; Zaiden, N | 1 |
| Gröber, U | 1 |
| Canene-Adams, K; Diamond, AM; Erdman, JW; Ford, NA; Lindshield, BL; Wallig, MA | 1 |
| Basu, HS; Guo, S; Kegel, SJ; Mahlum, A; Mehraein-Ghomi, F; Peters, NR; Wilding, G | 1 |
| Cervi, D; Fleshner, NE; Klotz, LH; Nam, RK; Pak, B; Sugar, LM; Venier, NA; Venkateswaran, V | 1 |
| Ching, YP; Chiu, YT; Lee, DT; Lee, TK; Ling, MT; Luk, SU; Ma, S; Nelson, C; Vasireddy, RS; Wong, YC; Yap, WN; Yap, YL | 1 |
| Cao, N; Guan, QL; Jiang, L; Ma, B; Mi, DH; Tian, JH; Wu, J; Yang, KH; Yang, SH; Yao, N | 1 |
| Ambrosini, GL; Beilby, J; de Klerk, NH; Musk, AW; Rossi, E | 1 |
| Aronson, WJ; Cohen, P; Elashoff, D; Heber, D; Henning, S; Konijeti, R; Ku, M; Moro, A; Said, JW; Shapiro, A; Sheikh, A | 1 |
| Adaramoye, OA; Akinloye, O; Olatunji, IK | 1 |
| Chaisanguanthum, RM; Chlebowski, RT; Jackson, DM; Menon, R | 1 |
| Caberto, C; Cao, X; Harris, R; Hennis, AJ; Leske, MC; Nemesure, B; Pakseresht, M; Sharma, S; Wilkens, LR; Wu, SY | 1 |
| Dunn, BK; Ford, LG; Minasian, LM; Richmond, ES; Ryan, AM | 1 |
| Calvo, A; Nguewa, PA | 1 |
| Godwin, M; Stratton, J | 1 |
| Aggarwal, BB; Campbell, SE; Dessus-Babus, S; Duffourc, M; Krishnan, K; Leesnitzer, LM; Lightner, J; Menter, DG; Newman, RA; Phillips, RB; Rudder, B; Stimmel, JB; Stone, WL; Whaley, SG; Yang, P | 1 |
| Freiser, H; Jiang, Q; Jiang, Z; Kim, CY; Li, G; Rao, X; Zhang, Q | 1 |
| Bennett, FI; Jackson, MD; Walker, SP; Younger, NM | 1 |
| Ercole, B; Parekh, DJ | 1 |
| Chin, J; Donnelly, B; Farley, A; Fleshner, NE; Gleave, M; Hersey, K; Jansz, K; Kapusta, L; Lacombe, L; Parulekar, WR; Siemens, DR; Tanguay, S; Trpkov, K; Tu, D | 1 |
| Baker, LH; Chin, JL; Crowley, JJ; Darke, AK; Ford, LG; Gaziano, JM; Goodman, GE; Goodman, PJ; Karp, DD; Klein, EA; Klotz, L; Lieber, MM; Lippman, SM; Lucia, MS; Meyskens, FL; Minasian, LM; Parnes, HL; Parsons, JK; Tangen, CM; Thompson, IM; Walther, PJ | 1 |
| Bagatini, MD; Battisti, IE; Battisti, V; Chiesa, J; Duarte, MM; Gonçalves, JF; Maders, LD; Morsch, VM; Reetz, LG; Schetinger, MR | 1 |
| McNeil, C | 1 |
| Constantinou, AI; Constantinou, C; Hyatt, JA; Neophytou, CM; Papas, KA; Vraka, P | 1 |
| Moyad, MA | 3 |
| Sato, S; Shirai, T; Takahashi, S | 1 |
| Klein, EA; Thompson, IM | 2 |
| Gaby, AR | 1 |
| Fried, ED; Hoskote, SS; Nadkarni, GN | 1 |
| Bubley, G; Klempner, SJ | 1 |
| Brown, AJ; Krycer, JR; Phan, L | 1 |
| Donovan, J; Fraser, WD; Gilbert, R; Hamdy, F; Lane, JA; Martin, RM; Metcalfe, C; Neal, DE | 1 |
| Chew, EY; Clemons, T | 1 |
| Fleshner, N; Hersey, K; Locke, J; Margel, D; Sorokin, K | 1 |
| Anderson, K; Arnold, KB; Baker, LH; Cook, ED; Crowley, JJ; Darke, AK; Goodman, PJ; Hartline, JA; Klein, EA; Meyskens, FL; Minasian, LM; Tangen, CM; Yee, M | 1 |
| Abdulah, R; Kameo, S; Koyama, H; Yamazaki, C | 1 |
| Fleshner, NE | 1 |
| Tom, J | 1 |
| Brants, HA; Goldbohm, RA; Schuurman, AG; van den Brandt, PA | 1 |
| Fleshner, NE; Klotz, LH; Venkateswaran, V | 2 |
| Cook, ED | 1 |
| Bostick, RM; Stern, MC; Taylor, JA; van Gils, CH | 1 |
| Mellon, JK; Pathak, SK; Sharma, RA | 1 |
| Graubard, BI; Greenberg, RS; Hayes, RB; Mayne, ST; Schoenberg, JB; Swanson, CA; Swanson, GM; Vogt, TM; Ziegler, RG | 1 |
| Chen, M; Huang, J; Li, R; Ni, J; Yeh, S; Zhang, Y | 1 |
| Oh, WK; Small, EJ | 1 |
| Hescheler, J; Sauer, H; Schallenberg, M; Wartenberg, M | 1 |
| Benghuzzi, H; Hughes, J; Richards, LR; Tucci, M | 1 |
| Basler, J; Leach, R; Naylor, S; Pollock, B; Thompson, IM; Troyer, D | 1 |
| Albanes, D; Coltman, C; Goodman, PJ; Klein, EA; Lippman, SM; Taylor, PR; Thompson, IM | 2 |
| Madersbacher, S; Ponholzer, A; Struhal, G | 1 |
| Freudenheim, JL; Hovey, K; McCann, SE; Muti, P; Nochajski, TH; Ram, M; Russell, M; Sempos, C; Trevisan, M | 1 |
| Thompson, TA; Wilding, G | 1 |
| Bode, P; Goldbohm, RA; van den Brandt, PA; Zeegers, MP | 1 |
| Ip, C; Zu, K | 1 |
| Boon, H; Brown, JB; Fleshner, N; Gavin, A; Goel, V; Gray, R; Stewart, M; Westlake, K | 1 |
| Goeman, L; Joniau, S; Oyen, R; Ponette, D; Roskams, T; Van der Aa, F; Van Poppel, H | 1 |
| Lanteri, VJ; Pak, RW; Sawczuk, IS; Scheuch, JR | 1 |
| Albanes, D; Basler, JW; Crawford, ED; Denis, LJ; Djavan, B; Fleshner, N; Johnson-Pais, TL; Klein, EA; Kristal, AR; Lucia, MS; McMann, MC; Parnes, HL; Piazza, GA; Platz, EA; Pollock, BH; Price, DK; Reichardt, JK; Tangen, CM; Thompson, IM; Tolcher, AW | 1 |
| Bartsch, G; Boccon Gibod, L; Djavan, B; Iversen, P; Marberger, M; Schulman, C; Teillac, P; Zlotta, A | 1 |
| Goulet, AC; Kagey, J; Meuillet, E; Nelson, MA; Porterfield, B; Prasad Cherukuri, D; Stratton, S | 1 |
| Huff, J | 1 |
| Calle, EE; Jacobs, EJ; McCullough, ML; Mondul, AM; Rodriguez, C; Thun, MJ | 1 |
| Basler, J; Hensley, D; Higgins, B; Jenkins, CA; Leach, R; Pollock, B; Thompson, IM; Troyer, D; von Merveldt, D | 1 |
| Campbell, LD; Gunawardena, K; Meikle, AW | 1 |
| Das, P; Kaplan, I | 1 |
| Altuwaijri, S; Yeh, S; Zhang, M | 1 |
| Allen, NE; Key, TJ; Morris, JS; Ngwenyama, RA | 1 |
| Basler, JW; Hernandez, J; Mahal, K; Thompson, IM | 2 |
| Krämer, K; Limpens, J; Obermüller-Jevic, UC; Pallapies, D; Schröder, FH; van Weerden, WM | 1 |
| Barella, L; Goralczyk, R; Lein, M; Schnorr, J; Siler, U; Spitzer, V; Wertz, K | 1 |
| Lucia, MS; Sakr, WA | 1 |
| Lippman, SM; Parnes, HL; Taylor, PR | 1 |
| Mazhar, D; Waxman, J | 1 |
| Fleshner, NE; Klotz, LH; Sugar, LM; Venkateswaran, V | 1 |
| Akçay, T; Alademir, AZ; Iynem, AH; Konukoğlu, D; Kural, AR; Obek, C | 1 |
| Arteaga, JR; Go, VL; Heber, D; Huerta, S; Lu, QY; Zhang, Q | 1 |
| Albanes, D; Coltman, CA; Cook, ED; Crowley, JJ; Fleshner, NE; Ford, LG; Gaziano, JM; Goodman, PJ; Hoque, A; Karp, DD; Khuri, FR; Klein, EA; Kristal, AR; Lieber, MM; Lippman, SM; Minasian, LM; Moinpour, CM; Parnes, HL; Probstfield, JL; Santella, RM; Schwartz, GG; Stanford, JL; Taylor, PR; Thomas, SM; Thompson, IM; Walther, PJ | 1 |
| Hawthorn, L; Ip, C; Zu, K | 1 |
| Iwasaki, M; Tsugane, S | 1 |
| Aisa, C; Conte, C; Floridi, A; Galli, F; Piroddi, M | 1 |
| Albanes, D; Hoque, A; King, IB; Kristal, AR; Pollak, MN; Santella, RM; Stanzyk, FZ | 1 |
| Dagnelie, PC; Delaere, KP; Hoenjet, KM; Oosterhof, GO; Wijckmans, NE; Zambon, JV | 1 |
| Chong, P; Rashid, P | 1 |
| Hampton, T | 1 |
| Babaian, RJ; Ho, SM; Kim, J; Lam, YW; Lieberman, R; Lippman, SM; Logothetis, C; McDonnell, TJ; Pettaway, CA; Pisters, LL; Sabichi, AL; Sun, P; Troncoso, P; Wood, CG | 1 |
| Arnold, JR; Grünheck, F; Hescheler, J; Hoffmann, E; Petros, J; Sauer, H; Schwindt, H; Wartenberg, M | 1 |
| Basu, A; Imrhan, V | 1 |
| Hakenberg, OW; Wirth, MP | 1 |
| Chang, HC; Chang, P; Chen, M; di Sant'Agnese, A; Messing, EM; Ni, J; Simons, B; Wen, X; Xie, S; Yao, J; Yeh, S; Yin, Y; Zhang, M | 1 |
| Anderson, KB; Arnold, KB; Campbell, R; Cook, ED; Craine, S; Hamilton, SJ; Harrington, JM; Lippman, SM; Minasian, LM; Moody-Thomas, S; Paskett, ED; Probstfield, JL | 1 |
| Andoh, J; Bandyopadhyay, S; Fokum, FD; Furuta, E; Horvath, E; Iiizumi, M; Malafa, MP; Neitzel, LT; Watabe, K; Zhan, R | 1 |
| Ege, C; Hieber, K; Hildabrand, A; Karikari, P; Kumar, KS; Mog, S; Papas, A; Parra, N; Petrovics, G; Raghavan, M; Seed, T; Singh, V; Srinivasan, V; Srivastava, S; Toles, R | 1 |
| Cukurovali, A; Erulas, FA; Karatas, F; Ozmen, H; Yalcin, O | 1 |
| Buring, JE; Gaziano, JM; Lee, IM | 1 |
| Albanes, D; Andriole, GL; Chatterjee, N; Dixon, LB; Hayes, RB; Kirsh, VA; Mayne, ST; Peters, U; Subar, AF; Urban, DA | 1 |
| Frazee, LA; Lowe, JF | 1 |
| Chen, CS; Huang, JW; Li, C; Lin, CH; Shiau, CW; Wang, DS; Weng, JR; Yang, CC | 1 |
| Herman, ZS; Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Bolder, CA; de Ridder, CM; Krämer, K; Limpens, J; Obermüller-Jevic, UC; Schröder, FH; van Weerden, WM; Wildhagen, MF | 1 |
| Dong, Y; Ip, C; Li, S; Lu, J; Malewicz, B; Marshall, J; Wu, Y; Zhang, H | 1 |
| Cooney, RV | 1 |
| Basu, A; Bennett, M; Grossie, B; Imrhan, V; Mills, N | 1 |
| Chang, E; Chang, P; Chemler, SR; James, NS; Lin, CC; Ni, J; Yeh, S; Yin, Y | 1 |
| Andriole, GL; Chanock, SJ; Chatterjee, N; Crawford, ED; Foster, CB; Hayes, RB; Peters, U; Reding, D; Schatzkin, A; Sturup, S | 1 |
| Crispen, PL; Golovine, K; Greenberg, RE; Horwitz, EM; Kolenko, VM; Makhov, P; Pollack, A; Uzzo, RG | 1 |
| Gescher, AJ; Jain, S; Marczylo, TH; Mellon, JK; Steward, WP; Thorpe, JF | 1 |
| Chen, M; DiMaggio, MA; Guo, Y; Ni, J; Yeh, S; Yin, Y | 1 |
| Albanes, D; Dixon, LB; Lawson, KA; Leitzmann, MF; Mouw, T; Schatzkin, A; Subar, AF; Weinstein, SJ; Wright, ME | 1 |
| Albanes, D; Lawson, KA; Männistö, S; Snyder, K; Taylor, PR; Virtamo, J; Weinstein, SJ; Wright, ME | 1 |
| Goeman, L; Joniau, S; Lerut, E; Oyen, R; Roskams, T; Van Poppel, H | 1 |
| Ni, J; Yeh, S | 1 |
| Berndt, SI; Chanock, S; Chatterjee, N; Hayes, RB; Huang, WY; Kang, D; Lee, KM; Park, SK; Peters, U; Reding, D; Welch, R | 1 |
| Kristal, AR; Littman, AJ; Patterson, RE; Peters, U; Potter, JD; White, E | 1 |
| Afaq, F; Khan, N; Mukhtar, H; Syed, DN | 1 |
| Eling, TE; Shim, M | 1 |
| Sarvis, JA; Thompson, IM | 1 |
| Jia, L; Kline, K; Sanders, BG; Snyder, RM; Yu, W | 1 |
| Hames, CG; Morris, JS; Polk, BF; Pressel, S; Rosner, B; Schneider, K; Stampfer, MJ; Taylor, JO; Willett, WC | 1 |
| Huttunen, J; Kontula, K | 1 |
| Brawley, OW; Coltman, CA; Ryan, A; Thompson, IM | 1 |
| Crespy, G | 1 |
| Israel, K; Kline, K; Sanders, BG | 1 |
| Bernasconi, F; Eichholzer, M; Gey, KF; Lüdin, E; Stähelin, HB | 1 |
| Aronson, W; Heber, D; Yip, I | 1 |
| Anagnostou, A; Sigounas, G; Steiner, M | 1 |
| Craft, NE; Lee, J; Nomura, AM; Stemmermann, GN | 1 |
| Coltman, CA; Crowley, J; Thompson, IM | 1 |
| Olson, KB; Pienta, KJ | 1 |
| Smigel, K | 1 |
| Albanes, D; Edwards, BK; Haapakoski, J; Hartman, AM; Heinonen, OP; Huttunen, JK; Koss, L; Mäenpää, H; Malila, N; Rautalahti, M; Ripatti, S; Taylor, PR; Teerenhovi, L; Virolainen, M; Virtamo, J | 1 |
| Aratri, E; Azzi, A; Boscoboinik, D; Clément, S; Ozer, NK; Ricciarelli, R; Spycher, S | 1 |
| Albanes, D; Hartman, AM; Hartman, TJ; Pietinen, P; Rautalahti, M; Tangrea, JA; Taylor, PR | 1 |
| Albanes, D; Taylor, PR | 1 |
| Bonn, D | 1 |
| Azzi, A; Boscoboinik, D; Pastori, M; Pfander, H | 1 |
| Herschberg, PI | 1 |
| Bernasconi, F; Eichholzer, M; Lüdin, E; Stähelin, HB | 1 |
| Fair, WR; Fleshner, N; Heston, WD; Huryk, R | 1 |
| Brumfield, SK; Moyad, MA; Pienta, KJ | 1 |
| Clinton, SK | 1 |
| Chan, JM; Giovannucci, EL; Ma, J; Rimm, EB; Stampfer, MJ; Willett, WC | 1 |
| Albanes, D; Dorgan, JF; Hartman, TJ; Tangrea, JA; Taylor, PR; Virtamo, J | 1 |
| Arvizu-Durazo, R; Freeman, VL; Liao, Y; Meydani, M; Pyle, J; Wan, Y; Yong, S | 1 |
| Bernasconi, F; Eichholzer, M; Gutzwiller, F; Lüdin, E; Stähelin, HB | 1 |
| Israel, K; Kline, K; Sanders, BG; Yu, W | 1 |
| de Vere White, R | 1 |
| Brawley, OW; Parnes, H | 1 |
| Gunawardena, K; Meikle, AW; Murray, DK | 1 |
| Calvert, RC; Mikhailidis, DP; Morgan, RJ; Thompson, CS | 1 |
| Blumenfeld, AJ; Casselman, B; Fleshner, N; Trachtenberg, J | 1 |
| Giovannucci, E | 1 |
| Alberg, AJ; Burke, A; Comstock, GW; Helzlsouer, KJ; Hoffman, S; Huang, HY; Morris, JS; Norkus, EP | 1 |
| Albanes, D; Barrett, MJ; Dorgan, JF; Hartman, TJ; Heinonen, OP; Tangrea, JA; Taylor, PR; Virtamo, J; Woodson, K | 1 |
| Ross, RK | 1 |
| Hagopian, K; Oberley, TD; Ripple, MO; Schatten, H; Weindruch, R | 1 |
| Fleshner, NE; Kucuk, O | 1 |
| Cohen, LA; Rose, DP; Wynder, EL | 1 |
| Abbou, CC; Chopin, DK; Cicco, A; de la Taille, A; Katz, A; Saint, F; Salomon, L; Vacherot, F | 1 |
| Papas, A; Vos, E | 1 |
| Miller, M | 1 |
| Brooks, JD; DePrimo, SE; Shinghal, R; Vidanes, G | 1 |
| Albanes, D; Coltman, CA; Crowley, JJ; Goodman, P; Hoque, A; Klein, EA; Lippman, SM; Santella, RM; Spitz, MR; Stanford, JL; Taylor, PR; Thompson, IM | 1 |
| Chan, JM; Giovannucci, EL | 1 |
| Bubley, GJ; Ko, YJ | 1 |
| DeFrancesco, L | 1 |
| Aruffo, A; Davis, PM; Kiener, PA; Knauff, M; Llewellyn, MB; Pitts, WJ; Salih, HR; Starling, GC | 1 |
| Hescheler, J; Klimm, B; Sauer, H; Wartenberg, M | 1 |
| Lagiou, A; Lagiou, P; Mucci, L; Trichopoulos, D; Tzonou, A | 1 |
| Barnes, S; Brawley, OW; Parnes, H | 1 |
| Ackermann, R; Jankevicius, F; Miller, SM | 1 |
| Gillatt, DA; Meyer, JP | 1 |
| Chang, E; Messing, EM; Ni, J; Yang, CR; Yeh, S; Zhang, Y | 1 |
| Balsubramaniam, A; McFadden, DW; Rose, AT; Somasundar, P; Vona-Davis, L; Yu, A | 1 |
| Fairfield, KM; Fletcher, RH | 1 |
| Hirose, M; Ito, N; Nakamura, A; Ogawa, K; Shirai, T; Takahashi, S | 1 |
| Abbey, H; Comstock, GW; Hsing, AW; Polk, BF | 1 |
| Bogdanovicz, JF; De Bruijn, A; Hayes, RB; Oishi, K; Raatgever, JW; Schroeder, FH; Van der Maas, PJ; Yoshida, O | 1 |
| Aromaa, A; Hakama, M; Hakulinen, T; Heliövaara, M; Knekt, P; Reunanen, A | 1 |
| Drago, JR; McDowell, G; Nesbitt, JA; Smith, J | 1 |
| Rama, BN; Ripoll, EA; Webber, MM | 1 |
| Bruning, PF; Egger, RJ; Odink, J; Schreurs, WH; Wedel, M | 1 |
88 review(s) available for d-alpha tocopherol and Cancer of Prostate
| Article | Year |
|---|---|
Dietary antioxidants and prostate cancer: a review.
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Coffee; Diet; Dietary Supplements; gamma-Tocopherol; Humans; Lycopene; Male; Polyphenols; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Tea; United States | 2013 |
Blood α-tocopherol, γ-tocopherol levels and risk of prostate cancer: a meta-analysis of prospective studies.
Topics: alpha-Tocopherol; gamma-Tocopherol; Humans; Male; Prostatic Neoplasms; Risk | 2014 |
Synergic effect of α-tocopherol and naringenin in transglutaminase-induced differentiation of human prostate cancer cells.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Drug Synergism; Flavanones; Humans; Male; Prostatic Neoplasms; Transglutaminases | 2011 |
The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events.
Topics: alpha-Tocopherol; Animal Diseases; Animals; Antioxidants; Arteriosclerosis; Ataxia; Cardiovascular Diseases; Free Radicals; gamma-Tocopherol; Gene Expression Regulation; Humans; Male; Prostatic Neoplasms; Protein Processing, Post-Translational; Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic | 2003 |
[Prostate cancer. Introduction].
Topics: 5-alpha Reductase Inhibitors; alpha-Tocopherol; Antineoplastic Agents, Hormonal; Diet, Fat-Restricted; Diet, Vegetarian; Enzyme Inhibitors; Finasteride; Genetic Therapy; Humans; Male; Neoadjuvant Therapy; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Selenium | 2005 |
Prostate cancer: chemoprevention update 2005.
Topics: alpha-Tocopherol; Antineoplastic Agents; Antioxidants; Carotenoids; Enzyme Inhibitors; Glycine max; Humans; Lycopene; Male; Phytotherapy; Prostatic Neoplasms; Selenium; Treatment Outcome | 2005 |
Vitamin E Intake and Risk of Prostate Cancer: A Meta-Analysis.
Topics: Antioxidants; Diet; Dietary Supplements; Humans; Male; Observational Studies as Topic; Prostatic Neoplasms; Risk; Vitamin E | 2022 |
Bioactive compounds of the Mediterranean diet and prostate cancer.
Topics: Anticarcinogenic Agents; Ascorbic Acid; Diet, Mediterranean; Humans; Lycopene; Male; Phytochemicals; Prostatic Neoplasms; Risk Factors; Vitamin E; Vitamins | 2018 |
Nonalcoholic Fatty Liver Disease and Obesity Treatment.
Topics: Bariatric Surgery; Body Weight; Diet; Exercise; Glucagon-Like Peptide 1; Humans; Inflammation; Insulin Resistance; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Obesity; Pioglitazone; Prostatic Neoplasms; Vitamin E; Weight Loss | 2019 |
Cancer prevention by tocopherols and tea polyphenols.
Topics: Animals; Anticarcinogenic Agents; Colonic Neoplasms; Disease Models, Animal; Humans; Lung Neoplasms; Male; Mice; Polyphenols; Prostatic Neoplasms; Tea; Tocopherols; Vitamin E | 2013 |
Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).
Topics: Aged; Animals; Anticarcinogenic Agents; Dietary Supplements; Drug Combinations; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Time Factors; Treatment Outcome; Vitamin E | 2013 |
Advances in prostate cancer chemoprevention: a translational perspective.
Topics: Androgen Antagonists; Animals; Anticarcinogenic Agents; Antioxidants; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Curcumin; Disease Models, Animal; Dutasteride; Finasteride; Flavonoids; Genistein; Humans; Lycopene; Male; Phytochemicals; Polyphenols; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Silybin; Silymarin; Tea; Vitamin E | 2013 |
[Pharmaco and diet based prostate cancer prevention].
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Diet; Eflornithine; Fruit; Histone Deacetylase Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Metformin; Minerals; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Selenium; Vegetables; Vitamin D; Vitamin E; Vitamins | 2013 |
Prostate cancer chemoprevention.
Topics: Adrenergic alpha-Antagonists; Animals; Anticarcinogenic Agents; Chemoprevention; Diet; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2013 |
Making personalized prostate cancer medicine a reality: challenges and opportunities in the re-establishment of gold standards.
Topics: Biomarkers, Tumor; Humans; Male; Neoplastic Cells, Circulating; Precision Medicine; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Vitamin E | 2013 |
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Topics: Aged; Case-Control Studies; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Humans; Incidence; Male; Middle Aged; Neoplasm Grading; Odds Ratio; Phospholipids; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Treatment Failure; United States; Vitamin E | 2013 |
Complementary and alternative medicine (CAM) in prostate and bladder cancer.
Topics: Acupuncture; Antineoplastic Agents; Antioxidants; Camellia sinensis; Complementary Therapies; Drugs, Chinese Herbal; Female; Humans; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Urinary Bladder Neoplasms; Vitamin E; Vitamins | 2013 |
Chemoprevention of prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Dietary Supplements; Dutasteride; Finasteride; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Lycopene; Male; Plant Extracts; Primary Prevention; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Selenium; Serenoa; Vitamin E | 2014 |
Future directions in the prevention of prostate cancer.
Topics: Antioxidants; Clinical Trials as Topic; Forecasting; Humans; Male; Primary Prevention; Prostatic Neoplasms; Selenium; Vitamin E | 2014 |
Prevention of prostate cancer: outcomes of clinical trials and future opportunities.
Topics: Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Finasteride; Humans; Inflammation; Male; Middle Aged; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin E | 2014 |
Vitamin D in blood and risk of prostate cancer: lessons from the Selenium and Vitamin E Cancer Prevention Trial and the Prostate Cancer Prevention Trial.
Topics: Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin D; Vitamin E | 2014 |
The use of dietary supplements to alleviate androgen deprivation therapy side effects during prostate cancer treatment.
Topics: Androgen Antagonists; Calcium, Dietary; Diabetes Mellitus, Type 2; Dietary Supplements; Fatty Acids; Humans; Male; Osteoporosis; Phytoestrogens; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin D; Vitamin E | 2014 |
Selenium and vitamin E for prostate cancer--justifications for the SELECT study.
Topics: Antioxidants; Cell Transformation, Neoplastic; Dietary Supplements; Humans; Male; Oxidative Stress; Prostatic Neoplasms; Selenium; Vitamin E | 2015 |
Relation of Vitamin E and Selenium Exposure to Prostate Cancer Risk by Smoking Status: A Review and Meta-Analysis.
Topics: Humans; Male; Prostatic Neoplasms; Regression Analysis; Risk Factors; Selenium; Smoking; Vitamin E | 2015 |
Selenium and Vitamin E Cancer Prevention Trial: a nutrient approach to prostate cancer prevention.
Topics: Antioxidants; Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Prostate cancer: a serious disease suitable for prevention.
Topics: Aged; Azasteroids; Cholestenone 5 alpha-Reductase; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Toremifene; Vitamin E | 2009 |
Chemoprevention of prostate cancer: what can be recommended to patients?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemoprevention; Cholestenone 5 alpha-Reductase; Enzyme Inhibitors; Flavonoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoflavones; Male; Phenols; Polyphenols; Prostatic Neoplasms; Selenium; Treatment Outcome; Vitamin D; Vitamin E; Vitamins | 2009 |
Cancer prevention: from 1727 to milestones of the past 100 years.
Topics: Cancer Vaccines; History, 18th Century; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Male; Neoplasms; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
[Chemical prevention of prostatic neoplasms].
Topics: 5-alpha Reductase Inhibitors; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2010 |
Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2010 |
A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Animals; Humans; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenomethionine; Vitamin E | 2010 |
Use of transgenic mice as models for prostate cancer chemoprevention.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Male; Mice; Mice, Transgenic; Models, Animal; Prostate; Prostatic Neoplasms; Selenium; Vitamin E | 2010 |
The effect of supplemental vitamins and minerals on the development of prostate cancer: a systematic review and meta-analysis.
Topics: Ascorbic Acid; beta Carotene; Dietary Supplements; Humans; Male; Minerals; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins; Zinc | 2011 |
Methods to predict and lower the risk of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Chemoprevention; Humans; Male; Prostatic Neoplasms; Risk Reduction Behavior; Selenium; Vitamin E | 2011 |
[Chemoprevention of prostate cancer].
Topics: Animals; Anticarcinogenic Agents; Carotenoids; Curcumin; Humans; Isoflavones; Lycopene; Male; Prostatic Neoplasms; Resveratrol; Stilbenes; Vitamin E | 2011 |
Chemoprevention of prostate cancer: an updated view.
Topics: 5-alpha Reductase Inhibitors; Chemoprevention; Humans; Male; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Trace Elements; Vitamin E; Vitamins | 2012 |
Complementary and alternative medicines in prostate cancer: from bench to bedside?
Topics: Antioxidants; Beverages; Complementary Therapies; Curcuma; Humans; Lythraceae; Male; Plant Extracts; Prostatic Neoplasms; Resveratrol; Selenium; Silybin; Silymarin; Stilbenes; Tea; Vitamin E; Vitamins | 2012 |
[Selenium supplementation trials for cancer prevention and the subsequent risk of type 2 diabetes mellitus: selenium and vitamin E cancer prevention trial and after].
Topics: Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2013 |
Vitamin E and prostate cancer.
Topics: Clinical Trials as Topic; Humans; Male; Prostatic Neoplasms; Vitamin E | 2002 |
Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review).
Topics: 5-alpha Reductase Inhibitors; Anticarcinogenic Agents; Antioxidants; Carotenoids; Chemoprevention; Dietary Fats; Enzyme Inhibitors; Humans; Lycopene; Male; Prostatic Neoplasms; Vitamin D; Vitamin E | 2003 |
Serum selenium and risk of prostate cancer in U.S. blacks and whites.
Topics: Adult; Aged; Black People; Case-Control Studies; Humans; Incidence; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Selenium; United States; Vitamin E; White People | 2003 |
Complementary and alternative therapies in prostate cancer.
Topics: Acupuncture Therapy; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Carotenoids; Complementary Therapies; Diet Therapy; Drug Design; Drugs, Chinese Herbal; Humans; Lycopene; Male; Plant Extracts; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium Compounds; Soybean Proteins; Survival Analysis; Treatment Outcome; United States; Vitamin E | 2002 |
Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials.
Topics: Antioxidants; Chemoprevention; Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Vitamin E | 2003 |
The selenium and vitamin E cancer prevention trial.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Male; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2003 |
Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Antioxidants; Chemoprevention; Clinical Trials as Topic; Humans; Male; Middle Aged; Models, Biological; Prostatic Neoplasms; Selenium; Vitamin E | 2003 |
Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
Topics: Antioxidants; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2002 |
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement.
Topics: Anticarcinogenic Agents; Antioxidants; Humans; Male; Prostatic Neoplasms; Research Design; Selenium; Vitamin E | 2004 |
Chemotherapeutic prevention studies of prostate cancer.
Topics: Anticarcinogenic Agents; Antioxidants; Azasteroids; Carotenoids; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Lycopene; Male; Prostatic Neoplasms; Vitamin E | 2004 |
Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
Topics: Clinical Trials as Topic; Drug Evaluation, Preclinical; Eligibility Determination; Humans; Male; Models, Biological; Organoselenium Compounds; Prostatic Neoplasms; Selenium; Sodium Selenite; Vitamin E | 2004 |
Prostate cancer prevention: what do we know now and when will we know more?
Topics: Antioxidants; Biomarkers, Tumor; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Male; Predictive Value of Tests; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Vitamin E | 2003 |
The role of PC-SPES, selenium, and vitamin E in prostate cancer.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Clinical Trials as Topic; Complementary Therapies; Drugs, Chinese Herbal; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2002 |
What's new in the field of prostate cancer chemoprevention?
Topics: Antioxidants; Chemoprevention; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2004 |
Update on chemoprevention of prostate cancer.
Topics: Aged; Carotenoids; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Finasteride; Humans; Lycopene; Male; Middle Aged; Prevalence; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Tea; United States; Vitamin D; Vitamin E | 2004 |
Potential pathologic markers for prostate chemoprevention studies.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Chemoprevention; Dietary Supplements; Humans; Male; Middle Aged; Neovascularization, Pathologic; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Assessment; Selenium; Sensitivity and Specificity; Survival Analysis; Vitamin E | 2004 |
Science peels the onion of selenium effects on prostate carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Dietary Supplements; DNA Damage; DNA, Neoplasm; Humans; Incidence; Male; Prostatic Neoplasms; Proteins; Randomized Controlled Trials as Topic; Selenium; Selenoproteins; Vitamin E | 2004 |
[Risk factors and current chemoprevention studies in prostate cancer].
Topics: 5-alpha Reductase Inhibitors; beta Carotene; Dairy Products; Diet, Fat-Restricted; Diet, Vegetarian; Enzyme Inhibitors; Exercise; Finasteride; Fish Oils; Humans; Life Style; Male; Meat; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Vitamin E | 2005 |
Selenium and vitamin E cancer prevention trial.
Topics: Black People; Humans; Male; Middle Aged; National Institutes of Health (U.S.); Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; United States; Vitamin E; White People | 2004 |
Can we prevent prostate cancer?
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Ascorbic Acid; Complementary Therapies; Dietary Supplements; Health Behavior; Humans; Male; Middle Aged; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Risk Factors; Selenium; Serenoa; Soy Foods; Tea; Vitamin E | 2005 |
What's new in the field of prostate cancer chemoprevention?
Topics: Antineoplastic Agents; Chemoprevention; Clinical Protocols; Cyclooxygenase Inhibitors; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2005 |
Vitamin E and prostate cancer: is vitamin E succinate a superior chemopreventive agent?
Topics: Animals; Antioxidants; Chemoprevention; Humans; In Vitro Techniques; Male; Mice; Prostatic Neoplasms; Tocopherols; Vitamin E | 2005 |
[Prevention of prostate cancer].
Topics: 5-alpha Reductase Inhibitors; Animals; Anticarcinogenic Agents; Azasteroids; Carotenoids; Dutasteride; Enzyme Inhibitors; Finasteride; Fishes; Flavonoids; Fruit; Humans; Isoflavones; Lycopene; Male; Neoplasms, Hormone-Dependent; Phenols; Polyphenols; Prostatic Neoplasms; Selenium; Soy Milk; Tea; Vegetables; Vitamin D; Vitamin E | 2005 |
Can prostate cancer be prevented?
Topics: Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2005 |
Update on prostate cancer chemoprevention.
Topics: 5-alpha Reductase Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Azasteroids; Carotenoids; Chemoprevention; Clinical Trials as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins | 2006 |
[Prostate cancer chemoprevention].
Topics: Carotenoids; Drug Therapy; Enzyme Inhibitors; Finasteride; Humans; Isoflavones; Lycopene; Male; Prostatic Neoplasms; Selenium; Soy Foods; Vitamin A; Vitamin D; Vitamin E | 2005 |
Tocopherols and prostate cancer.
Topics: Humans; Male; Prostatic Neoplasms; Risk Assessment; Risk Factors; Tocopherols; United States; Vitamin E | 2006 |
A review of phase III clinical trials of prostate cancer chemoprevention.
Topics: Antineoplastic Agents; Azasteroids; Clinical Trials, Phase III as Topic; Dutasteride; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Prostatic Neoplasms; Selenium Compounds; Vitamin E | 2007 |
The roles of alpha-vitamin E and its analogues in prostate cancer.
Topics: Animals; Antioxidants; Humans; Male; Prostatic Neoplasms; Tocopherols; Vitamin E | 2007 |
Chemoprevention of prostate cancer through dietary agents: progress and promise.
Topics: Carotenoids; Chemoprevention; Clinical Trials as Topic; Dietary Supplements; Flavonoids; Humans; Lycopene; Male; Phytoestrogens; Prostatic Neoplasms; Selenium Compounds; Vitamin D; Vitamin E | 2007 |
Androgens and prevention of prostate cancer.
Topics: Androgens; Anticarcinogenic Agents; Azasteroids; Dutasteride; Finasteride; Humans; Male; Prostate; Prostatic Neoplasms; Selenium; Signal Transduction; Vitamin E | 2008 |
Chemoprevention of prostate cancer.
Topics: Androgen Antagonists; Cholesterol; Depression, Chemical; Diet; Eflornithine; Finasteride; Humans; Male; Prostatic Neoplasms; Retinoids; Vitamin E | 1995 |
Nutritional approaches to the prevention of prostate cancer progression.
Topics: Animals; Dietary Fats; Dietary Fiber; Humans; Male; Nutritional Physiological Phenomena; Prostatic Neoplasms; Selenium; Soybean Proteins; Vitamin E | 1996 |
Vitamin E, alpha- and gamma-tocopherol, and prostate cancer.
Topics: Dietary Fats; Disease Progression; Drug Screening Assays, Antitumor; Humans; Incidence; Male; Morbidity; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin E | 1999 |
Prostate cancer prevention trials in the USA.
Topics: 5-alpha Reductase Inhibitors; Aged; Animals; Clinical Trials as Topic; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Rabbits; Risk Factors; Selenium; Vitamin E | 2000 |
Nutritional aspects of prostate cancer: a review.
Topics: Calcium, Dietary; Carotenoids; Estrogens, Non-Steroidal; Fatty Acids; Humans; Isoflavones; Male; Nutritional Physiological Phenomena; Phytoestrogens; Plant Preparations; Plants, Edible; Prostatic Neoplasms; Selenium; Soybean Proteins; Vegetables; Vitamin D; Vitamin E | 2000 |
The role of molecular genetics in chemoprevention studies of prostate cancer.
Topics: Androgens; Anticarcinogenic Agents; Antineoplastic Agents; Biomarkers, Tumor; Drug Evaluation; Genetic Testing; Humans; Male; Prostatic Neoplasms; Signal Transduction; Vitamin E | 2001 |
Nutrition and prostate cancer: a proposal for dietary intervention.
Topics: Animals; Dietary Fats; Dietary Supplements; Disease Models, Animal; Glycine max; Humans; Male; Prospective Studies; Prostatic Neoplasms; Retrospective Studies; Selenium; Tumor Cells, Cultured; Vitamin E | 1994 |
[Cancer of the prostate: influence of nutritional factors. Vitamins, antioxidants and trace elements].
Topics: Aged; Animals; Antioxidants; Ascorbic Acid; beta Carotene; Cadmium; Carotenoids; Clinical Trials as Topic; Cohort Studies; Follow-Up Studies; Humans; Lycopene; Male; Mice; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Solanum lycopersicum; Time Factors; Trace Elements; Tumor Cells, Cultured; Vitamin A; Vitamin D; Vitamin E; Vitamins | 2001 |
Prostate cancer: epidemiology and prevention.
Topics: Animals; Clinical Trials as Topic; Humans; Male; Meat; Nutritional Physiological Phenomena; Prospective Studies; Prostatic Neoplasms; Selenium; Vitamin E | 2000 |
Prevention of prostate cancer.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adenocarcinoma; Androgen Antagonists; Androgens; Animals; Anticarcinogenic Agents; Antioxidants; Carotenoids; Case-Control Studies; Cohort Studies; Dietary Fats; Double-Blind Method; Enzyme Inhibitors; Finasteride; Genetic Predisposition to Disease; Humans; Incidence; Insulin-Like Growth Factor I; Life Style; Lycopene; Male; Mice; Mice, Transgenic; Micronutrients; Neoplasms, Hormone-Dependent; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Racial Groups; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Soybean Proteins; Vitamin D; Vitamin E | 2001 |
Vegetables, fruits, associated micronutrients, and risk of prostate cancer.
Topics: Ascorbic Acid; Carotenoids; Developed Countries; Epidemiologic Studies; Fruit; Humans; Male; Prostatic Neoplasms; Risk Factors; Vegetables; Vitamin E | 2001 |
Prostate cancer in the older man.
Topics: Age Factors; Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Antioxidants; Brachytherapy; Dietary Fats; Humans; Male; Middle Aged; Mitoxantrone; Nitriles; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Selenium; Tosyl Compounds; Vitamin E | 2001 |
The future of prostate cancer prevention.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Anticarcinogenic Agents; Antioxidants; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diet; Double-Blind Method; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Selenium; Soybean Proteins; Treatment Outcome; Vitamin A; Vitamin D; Vitamin E | 2001 |
Nutrition and risk of prostate cancer.
Topics: Antioxidants; Ascorbic Acid; Carotenoids; Diet; Dietary Fats; Estrogens, Non-Steroidal; Humans; Isoflavones; Male; Meat; Phytoestrogens; Plant Preparations; Plants; Prostatic Neoplasms; Selenium; Tocopherols; Vitamin A; Vitamin D; Vitamin E | 2002 |
Can diet affect prostate cancer?
Topics: Dietary Fats; Humans; Male; Prostatic Neoplasms; Soybean Proteins; Vitamin A; Vitamin D; Vitamin E | 2002 |
Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?
Topics: beta Carotene; Comorbidity; Dietary Supplements; Female; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Smoking; Vitamin E | 2002 |
Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women.
Topics: Acupuncture; Adult; Antidepressive Agents; Breast Neoplasms; Complementary Therapies; Dietary Supplements; Female; Hot Flashes; Humans; Life Style; Male; Middle Aged; Phytotherapy; Postmenopause; Prostatic Neoplasms; Soybean Proteins; Trifolium; Vitamin E | 2002 |
Vitamins for chronic disease prevention in adults: scientific review.
Topics: Ascorbic Acid; Avitaminosis; Blood Coagulation; Breast Neoplasms; Carotenoids; Chronic Disease; Colorectal Neoplasms; Coronary Disease; Dietary Supplements; Female; Folic Acid; Fractures, Bone; Humans; Lung Neoplasms; Male; Neoplasms; Neural Tube Defects; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin B 12; Vitamin B 6; Vitamin D; Vitamin E; Vitamin K; Vitamins | 2002 |
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholesterol; Colonic Neoplasms; Female; Finland; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Precancerous Conditions; Prostatic Neoplasms; Random Allocation; Registries; Risk Factors; Sampling Studies; Sex Factors; Smoking; Surveys and Questionnaires; Vitamin A; Vitamin E | 1988 |
49 trial(s) available for d-alpha tocopherol and Cancer of Prostate
| Article | Year |
|---|---|
Serum Retinol and Risk of Overall and Site-Specific Cancer in the ATBC Study.
Topics: Aged; Alcohol Drinking; alpha-Tocopherol; beta Carotene; Body Weights and Measures; Cholesterol, HDL; Chromatography, High Pressure Liquid; Diet; Dietary Supplements; Double-Blind Method; Exercise; Finland; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prostatic Neoplasms; Residence Characteristics; Smoking; Socioeconomic Factors | 2020 |
Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a γ-Tocopherol-Rich Vitamin E Mixture.
Topics: alpha-Tocopherol; Animals; Dietary Supplements; gamma-Tocopherol; Humans; Male; Prostate; Prostatic Neoplasms; Tocopherols; Vitamin E | 2021 |
Prospective serum metabolomic profiling of lethal prostate cancer.
Topics: alpha-Tocopherol; Amino Acids; beta Carotene; Biomarkers, Tumor; Case-Control Studies; Chromatography, Liquid; Double-Blind Method; Fatty Acids; Humans; Logistic Models; Male; Metabolomics; Middle Aged; Odds Ratio; Prospective Studies; Prostatic Neoplasms; Risk Factors; Tandem Mass Spectrometry | 2019 |
Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.
Topics: Adenoma; Aged; alpha-Tocopherol; Antioxidants; Colorectal Neoplasms; Dietary Supplements; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Selenomethionine; Sigmoidoscopy | 2017 |
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.
Topics: Aged; alpha-Tocopherol; Antioxidants; Ascorbic Acid; Dietary Supplements; Double-Blind Method; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Treatment Outcome; Vitamin E | 2009 |
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; alpha-Tocopherol; Antioxidants; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Selenium; Selenomethionine; Treatment Outcome; Vitamin E | 2009 |
Association of variants in two vitamin e transport genes with circulating vitamin e concentrations and prostate cancer risk.
Topics: alpha-Tocopherol; beta Carotene; Carrier Proteins; Diet; Dietary Supplements; Double-Blind Method; Genetic Variation; Humans; Lipoproteins; Male; Meat; Middle Aged; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Regression Analysis; Risk Factors; Tissue Plasminogen Activator; Trans-Activators; Vitamin E | 2009 |
Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer.
Topics: Aged; alpha-Tocopherol; Analysis of Variance; Anticarcinogenic Agents; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Confounding Factors, Epidemiologic; Drug Therapy, Combination; Feasibility Studies; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Genetic Markers; Humans; Immunohistochemistry; Ki-67 Antigen; Linear Models; Male; Microdissection; Middle Aged; Neoadjuvant Therapy; Oligonucleotide Array Sequence Analysis; Polymerase Chain Reaction; Prostate; Prostatectomy; Prostatic Neoplasms; Reproducibility of Results; Research Design; Reverse Transcriptase Polymerase Chain Reaction; Selenomethionine; Treatment Failure; Tumor Suppressor Protein p53 | 2009 |
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.
Topics: Aged; alpha-Tocopherol; beta Carotene; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Vitamin A | 2009 |
Serum retinol and risk of prostate cancer.
Topics: Aged; Alcohol Drinking; alpha-Tocopherol; beta Carotene; Chromatography, High Pressure Liquid; Double-Blind Method; Female; Finland; Humans; Incidence; Male; Middle Aged; Placebos; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Registries; Risk Assessment; Risk Factors; Smoking; Surveys and Questionnaires; Vitamin A; White People | 2011 |
Serum total and HDL cholesterol and risk of prostate cancer.
Topics: Aged; alpha-Tocopherol; beta Carotene; Cholesterol; Cholesterol, HDL; Cohort Studies; Double-Blind Method; Finland; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Treatment Outcome | 2011 |
Circulating thyroxine, thyroid-stimulating hormone, and hypothyroid status and the risk of prostate cancer.
Topics: Aged; alpha-Tocopherol; beta Carotene; Case-Control Studies; Genetic Association Studies; Humans; Hypothyroidism; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Thyroid Function Tests; Thyrotropin; Thyroxine | 2012 |
Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study.
Topics: Adenocarcinoma; Aged; alpha-Tocopherol; Amino Acid Substitution; Anticarcinogenic Agents; beta Carotene; Case-Control Studies; Cell Differentiation; Cohort Studies; DNA Mutational Analysis; Finland; Genetic Predisposition to Disease; Genotype; Humans; Incidence; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Risk; Smoking; Transcription Factors | 2003 |
The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
Topics: Aged; alpha-Tocopherol; Antioxidants; beta Carotene; Biomarkers, Tumor; Carotenoids; Case-Control Studies; Double-Blind Method; Female; gamma-Tocopherol; Humans; Lung Neoplasms; Male; Micronutrients; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Factors; Smoking; Statistics as Topic; Treatment Outcome; Vitamin A | 2003 |
The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
Topics: alpha-Tocopherol; Antioxidants; Dehydroepiandrosterone; Dietary Supplements; Humans; Insulin-Like Growth Factor I; Male; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Vitamin E | 2005 |
Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.
Topics: Age Factors; Aged; alpha-Tocopherol; beta Carotene; Case-Control Studies; Double-Blind Method; Finland; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Vitamin D; Vitamins | 2007 |
The effect of walnut intake on factors related to prostate and vascular health in older men.
Topics: Aged; alpha-Tocopherol; Biomarkers; Cross-Over Studies; Dietary Supplements; gamma-Tocopherol; Humans; Juglans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Factors; Tocopherols; Triglycerides; Vascular Diseases | 2008 |
Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Biopsy; Humans; Male; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Vitamin E; Vitamins | 2022 |
Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
Topics: Aged; Case-Control Studies; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Humans; Incidence; Male; Middle Aged; Neoplasm Grading; Odds Ratio; Phospholipids; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Selenium; Treatment Failure; United States; Vitamin E | 2013 |
Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer.
Topics: Aged; Apolipoprotein A-V; Apolipoproteins A; Carrier Proteins; Case-Control Studies; Genetic Predisposition to Disease; Genetic Variation; Genome-Wide Association Study; Humans; Male; Mass Screening; Membrane Transport Proteins; Middle Aged; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Scavenger Receptors, Class B; United States; Vitamin E; White People | 2014 |
Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Adult; Case-Control Studies; Humans; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Risk; Selenium; Vitamin D; Vitamin E; Vitamins | 2014 |
A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Antioxidants; Case-Control Studies; Genotype; Homeodomain Proteins; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Transcription Factors; Vitamin E; Vitamins | 2014 |
Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial.
Topics: Aged; Antioxidants; Ascorbic Acid; Cohort Studies; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Neoplasms; Physicians; Prostatic Neoplasms; Risk Factors; United States; Vitamin E | 2014 |
Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.
Topics: Aged; Aging; Antioxidants; Cataract; Cataract Extraction; Double-Blind Method; Drug Combinations; Endpoint Determination; Humans; Incidence; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Selenomethionine; Surveys and Questionnaires; Vitamin E | 2015 |
Difference in Association of Obesity With Prostate Cancer Risk Between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Anticarcinogenic Agents; Black or African American; Body Mass Index; Canada; Chi-Square Distribution; Health Status Disparities; Humans; Incidence; Male; Middle Aged; Obesity; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Puerto Rico; Risk Assessment; Risk Factors; Selenium; Time Factors; Treatment Outcome; United States; Vitamin E; White People | 2015 |
A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antioxidants; Chromans; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Vitamin E | 2016 |
Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.
Topics: Aged; Biological Transport; Biomarkers, Tumor; Cohort Studies; Genetic Variation; Humans; Male; Middle Aged; Neoplasm Grading; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2016 |
Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.
Topics: Aged; Anticarcinogenic Agents; Antioxidants; Databases, Factual; Double-Blind Method; Endpoint Determination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Research Design; Retrospective Studies; Risk Factors; Selenium; Time Factors; Treatment Outcome; United States; Vitamin E | 2016 |
The negative results of the SELECT study do not necessarily discredit the selenium-cancer prevention hypothesis.
Topics: Aged; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenomethionine; Vitamin E | 2009 |
Serum levels of folate, lycopene, β-carotene, retinol and vitamin E and prostate cancer risk.
Topics: Aged; beta Carotene; Carotenoids; Case-Control Studies; Cohort Studies; Folic Acid; Humans; Lycopene; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin E | 2010 |
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
Topics: Disease Progression; Disease-Free Survival; Double-Blind Method; Humans; Male; Middle Aged; Patient Compliance; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Soybean Proteins; Testosterone; Vitamin E | 2011 |
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Antioxidants; Dietary Supplements; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Risk; Selenium; Vitamin E | 2011 |
Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
Topics: Case-Control Studies; Humans; Kallikreins; Male; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Risk Factors; United Kingdom; Vitamin A; Vitamin D; Vitamin E | 2012 |
Moving a randomized clinical trial into an observational cohort.
Topics: Adult; Aged; Aged, 80 and over; Canada; Clinical Trials Data Monitoring Committees; Cohort Studies; Data Collection; Dietary Supplements; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Follow-Up Studies; Humans; Male; Middle Aged; National Cancer Institute (U.S.); Placebos; Prostatic Neoplasms; Puerto Rico; Randomized Controlled Trials as Topic; Research Design; Selenium; United States; Vitamin E | 2013 |
Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Case-Control Studies; Codon; DNA Repair; DNA-Binding Proteins; Eating; Follow-Up Studies; Gene Frequency; Genotype; Humans; Lycopene; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors; Treatment Outcome; Vitamin E; X-ray Repair Cross Complementing Protein 1 | 2002 |
Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
Topics: Aged; Biopsy, Needle; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2003 |
Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Coenzymes; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Hormones; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Selenium; Ubiquinone; Vitamin E | 2005 |
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
Topics: Analysis of Variance; Antioxidants; Double-Blind Method; Humans; Male; Middle Aged; Preoperative Care; Prostatectomy; Prostatic Neoplasms; Proteomics; Selenomethionine; Vitamin E | 2005 |
Serum and dietary vitamin E in relation to prostate cancer risk.
Topics: Aged; Anticarcinogenic Agents; Antioxidants; beta Carotene; Chromatography, High Pressure Liquid; Cohort Studies; Diet; Dietary Supplements; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Smoking; Vitamin E | 2007 |
Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia.
Topics: Adult; Aged; Dietary Supplements; Follow-Up Studies; Humans; Isoflavones; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors; Selenium; Soy Foods; Treatment Outcome; Vitamin E | 2007 |
Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.
Topics: Aged; Alanine; Alleles; Antioxidants; Case-Control Studies; Diet; Exons; Free Radical Scavengers; Genetic Variation; Humans; Isoenzymes; Male; Middle Aged; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors; Smoking; Superoxide Dismutase; Superoxide Dismutase-1; Valine; Vitamin E; White People | 2007 |
Prediagnostic serum selenium and risk of cancer.
Topics: Adult; Aged; Black People; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Risk; Selenium; United States; Vitamin A; Vitamin E; White People | 1983 |
[SETTI-Study and antioxidants--more questions than answers].
Topics: Antioxidants; beta Carotene; Carotenoids; Coronary Disease; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Vitamin E | 1994 |
Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Vitamin D; Vitamin E | 1997 |
Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.
Topics: Anticarcinogenic Agents; beta Carotene; Double-Blind Method; Humans; Incidence; Male; Prostatic Neoplasms; Treatment Outcome; Vitamin E | 1998 |
The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study.
Topics: Aged; beta Carotene; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Smoking; Vitamin E | 1998 |
Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study.
Topics: Age Factors; Ascorbic Acid; Cholesterol; Cohort Studies; Colonic Neoplasms; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prospective Studies; Prostatic Neoplasms; Risk Factors; Smoking; Stomach Neoplasms; Switzerland; Vitamin A; Vitamin E | 2000 |
Effects of long-term alpha-tocopherol supplementation on serum hormones in older men.
Topics: Alcohol Drinking; Androstenedione; Cholesterol; Dehydroepiandrosterone; Eating; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Multivariate Analysis; Prolactin; Prostatic Neoplasms; Radioimmunoassay; Regression Analysis; Sex Hormone-Binding Globulin; Smoking; Testosterone; Vitamin E | 2001 |
Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Colorectal Neoplasms; Double-Blind Method; Epidemiologic Studies; Genetic Markers; Gonadal Steroid Hormones; Humans; Leptin; Lung Neoplasms; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Factors; Selenium; United States; Vitamin E | 2001 |
228 other study(ies) available for d-alpha tocopherol and Cancer of Prostate
| Article | Year |
|---|---|
Suillusin, a unique benzofuran from the mushroom Suillus granulatus.
Topics: Antineoplastic Agents, Phytogenic; Antioxidants; Basidiomycota; Benzofurans; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Inhibitory Concentration 50; Korea; Lung Neoplasms; Magnetic Resonance Spectroscopy; Male; Melanoma; Molecular Structure; Ovarian Neoplasms; Prostatic Neoplasms; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Tumor Cells, Cultured; Vitamin E | 2001 |
Hair dye use and prostate cancer risk: A prospective analysis in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study cohort.
Topics: alpha-Tocopherol; beta Carotene; Cohort Studies; Hair Dyes; Humans; Male; Prostatic Neoplasms; Risk Factors | 2022 |
A 28-year prospective analysis of serum vitamin E, vitamin E-related genetic variation and risk of prostate cancer.
Topics: alpha-Tocopherol; beta Carotene; Humans; Male; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Vitamin E | 2022 |
Association between Vitamin A and E Forms and Prostate Cancer Risk in the Singapore Prostate Cancer Study.
Topics: alpha-Tocopherol; beta Carotene; Beta-Cryptoxanthin; Case-Control Studies; Humans; Lutein; Male; Prostatic Neoplasms; Singapore; Tocotrienols; Ubiquinone; Vitamin A | 2023 |
Treatment of Metastatic or High-Risk Solid Cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports.
Topics: Adult; Aged; alpha-Tocopherol; Antineoplastic Agents; Breast Neoplasms; Celecoxib; Colonic Neoplasms; Cyclooxygenase 2 Inhibitors; Cyclophosphamide; Dexamethasone; Diterpenes; Female; Humans; Immunosuppressive Agents; Interleukins; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Retinyl Esters; Tumor Burden; Tumor Escape; Vitamin A; Vitamins | 2019 |
γ-Tocotrienol and α-Tocopherol Ether Acetate Enhance Docetaxel Activity in Drug-Resistant Prostate Cancer Cells.
Topics: alpha-Tocopherol; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chromans; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Ether; Humans; Male; Prostatic Neoplasms; Vitamin E | 2020 |
Upregulation of pERK and c-JUN by γ-tocotrienol and not α-tocopherol are essential to the differential effect on apoptosis in prostate cancer cells.
Topics: alpha-Tocopherol; Antioxidants; Apoptosis; Biomarkers, Tumor; Cell Survival; gamma-Tocopherol; Gene Expression Regulation, Neoplastic; Humans; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Prostatic Neoplasms; Proto-Oncogene Proteins c-jun; Tumor Cells, Cultured; Up-Regulation | 2020 |
Reduction of oxidative stress and ornithine decarboxylase expression in a human prostate cancer cell line PC-3 by a combined treatment with α-tocopherol and naringenin.
Topics: alpha-Tocopherol; Antioxidants; Cell Proliferation; Drug Synergism; Flavanones; Glutathione; Humans; Lipid Peroxidation; Male; Ornithine Decarboxylase; Oxidation-Reduction; Oxidative Stress; PC-3 Cells; Polyamines; Prostatic Neoplasms; Thiobarbituric Acid Reactive Substances | 2021 |
Combination Effect of Bowman-Birk Inhibitor and α-Tocopheryl Succinate on Prostate Cancer Stem-Like Cells.
Topics: alpha-Tocopherol; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Male; Neoplastic Stem Cells; Prostatic Neoplasms; Trypsin Inhibitor, Bowman-Birk Soybean | 2019 |
Pigmentation-related phenotypes and risk of prostate cancer.
Topics: Aged; alpha-Tocopherol; beta Carotene; Disease Susceptibility; Eye Color; Finland; Hair Color; Humans; Male; Middle Aged; Phenotype; Proportional Hazards Models; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Registries; Skin Pigmentation | 2013 |
Antioxidant and vitamin E transport genes and risk of high-grade prostate cancer and prostate cancer recurrence.
Topics: Aged; alpha-Tocopherol; Biomarkers, Tumor; Carrier Proteins; gamma-Tocopherol; Humans; Lipoproteins; Logistic Models; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Polymorphism, Single Nucleotide; Proportional Hazards Models; Prostatic Neoplasms; Retrospective Studies; Risk Factors; Superoxide Dismutase; Superoxide Dismutase-1; Trans-Activators; Vitamin E | 2013 |
α-Tocopheryl succinate pre-treatment attenuates quinone toxicity in prostate cancer PC3 cells.
Topics: Active Transport, Cell Nucleus; alpha-Tocopherol; Antioxidants; Apoptosis; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Docetaxel; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Glutathione; Heme Oxygenase-1; Humans; Hydrogen Peroxide; Hydroquinones; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Paraquat; Prostatic Neoplasms; Protoporphyrins; RNA Interference; RNA, Small Interfering; Taxoids | 2014 |
Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocolpherol, beta-carotene cancer prevention (ATBC) study.
Topics: Adenocarcinoma; alpha-Tocopherol; beta Carotene; Biomarkers, Tumor; Humans; Male; Metabolome; Metabolomics; Middle Aged; Prospective Studies; Prostatic Neoplasms | 2015 |
Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.
Topics: Adult; alpha-Tocopherol; Biomarkers; Carotenoids; Case-Control Studies; Cohort Studies; Cross-Sectional Studies; Humans; Lycopene; Male; Meta-Analysis as Topic; Middle Aged; Neoplasm Grading; Neoplasm Staging; Observational Studies as Topic; Prospective Studies; Prostate; Prostatic Neoplasms; Risk Factors; Vitamin A | 2015 |
Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells.
Topics: alpha-Tocopherol; Androgens; Antioxidants; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Immunohistochemistry; Male; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Vitamin E | 2016 |
Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
Topics: Adenocarcinoma; alpha-Tocopherol; Anticarcinogenic Agents; beta Carotene; Biomarkers, Tumor; Carotenoids; Cell Line, Tumor; Cell Proliferation; Disease Progression; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genistein; Humans; Lycopene; Male; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Selenomethionine; Vitamins | 2008 |
Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
Topics: Aged; alpha-Tocopherol; beta Carotene; Biomarkers, Tumor; Body Mass Index; Body Size; Finland; Follow-Up Studies; Humans; Life Style; Male; Medical History Taking; Middle Aged; Multivariate Analysis; Odds Ratio; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Smoking | 2008 |
Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
Topics: Aged; alpha-Tocopherol; Antioxidants; Case-Control Studies; Cohort Studies; Europe; gamma-Tocopherol; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prostatic Neoplasms; Risk Factors; Selenium; Smoking | 2008 |
In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Evaluation, Preclinical; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Receptors, Androgen; Receptors, Calcitriol; Sulfonic Acids; Vitamin E; Xenograft Model Antitumor Assays | 2009 |
Selenium and vitamin E: interesting biology and dashed hope.
Topics: alpha-Tocopherol; Anticarcinogenic Agents; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Male; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenomethionine; Treatment Failure | 2009 |
Antioxidants: SELECTed out?
Topics: alpha-Tocopherol; Antioxidants; Ascorbic Acid; Clinical Trials as Topic; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium | 2009 |
alpha-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis.
Topics: alpha-Tocopherol; Cell Line, Tumor; Humans; JNK Mitogen-Activated Protein Kinases; Male; Prostatic Neoplasms; Protein Phosphatase 2; Receptors, Androgen; Signal Transduction; Sp1 Transcription Factor; Transcription, Genetic | 2009 |
Null activity of selenium and vitamin e as cancer chemopreventive agents in the rat prostate.
Topics: Adenocarcinoma; Alkylating Agents; alpha-Tocopherol; Androgens; Animals; Antioxidants; Cyproterone Acetate; Disease Models, Animal; Drug Therapy, Combination; Male; Methylnitrosourea; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Rats, Wistar; Selenium Compounds; Selenomethionine; Testosterone; Vitamin E | 2010 |
Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.
Topics: Adenocarcinoma; alpha-Tocopherol; Androgens; Animals; Antioxidants; Dietary Supplements; Disease Models, Animal; Drug Therapy, Combination; Estradiol; Estrogens; Male; Oxidative Stress; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Selenomethionine; Testosterone | 2010 |
alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate.
Topics: alpha-Tocopherol; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Ascorbic Acid; Cell Death; Cell Line, Tumor; Drug Screening Assays, Antitumor; Drug Synergism; Fibroblasts; Humans; Lysosomes; Male; Mitochondria; Prostatic Neoplasms; Reactive Oxygen Species; Vitamin K 3 | 2010 |
Tocopherol transfer protein sensitizes prostate cancer cells to vitamin E.
Topics: alpha-Tocopherol; Apoptosis; Blotting, Western; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; HEK293 Cells; Hep G2 Cells; Humans; Male; Microscopy, Fluorescence; Mitochondria; Mutation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Reactive Oxygen Species; RNA Interference; Time Factors; Vitamin E; Vitamins | 2010 |
Association of serum α-tocopherol with sex steroid hormones and interactions with smoking: implications for prostate cancer risk.
Topics: Adult; alpha-Tocopherol; Carcinoma; Cross-Sectional Studies; Gonadal Steroid Hormones; Humans; Male; Middle Aged; Nutrition Surveys; Prostatic Neoplasms; Risk Factors; Sex Hormone-Binding Globulin; Smoking; Testosterone; Young Adult | 2011 |
Genetic variation in myeloperoxidase modifies the association of serum α-tocopherol with aggressive prostate cancer among current smokers.
Topics: alpha-Tocopherol; Case-Control Studies; gamma-Tocopherol; Gene Expression Regulation, Enzymologic; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Odds Ratio; Oxidative Stress; Peroxidase; Polymorphism, Genetic; Prostatic Neoplasms; Smoking | 2011 |
Serum β-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study.
Topics: Adult; Aged; Alcohol Drinking; alpha-Linolenic Acid; alpha-Tocopherol; Antioxidants; beta Carotene; Cholesterol; Chromatography, High Pressure Liquid; Finland; Follow-Up Studies; Humans; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors; Smoking; Surveys and Questionnaires; Vitamin A | 2012 |
Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity.
Topics: alpha-Tocopherol; Animals; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Glutathione; Heme Oxygenase-1; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Prostatic Neoplasms; Protein Transport; Reactive Oxygen Species | 2012 |
γ-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins.
Topics: alpha-Tocopherol; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin E; DNA Replication; Down-Regulation; Enzyme Induction; gamma-Tocopherol; GTP-Binding Proteins; Humans; Male; Prostatic Neoplasms; Protein Glutamine gamma Glutamyltransferase 2; Transglutaminases; Up-Regulation; Vitamins | 2013 |
Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
Topics: Aged; alpha-Tocopherol; Case-Control Studies; gamma-Tocopherol; Humans; Male; Mass Screening; Middle Aged; Prostatic Neoplasms; Risk | 2012 |
No effect of a high-fat diet on promotion of sex hormone-induced prostate and mammary carcinogenesis in the Noble rat model.
Topics: alpha-Tocopherol; Analysis of Variance; Animals; Breast; Carcinogens; Chi-Square Distribution; Chromatography, High Pressure Liquid; Dietary Fats; Estradiol; Female; Male; Mammary Neoplasms, Experimental; Prostatic Neoplasms; Random Allocation; Rats; Rats, Inbred Strains; Testosterone | 2002 |
Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up.
Topics: Aged; alpha-Tocopherol; Antioxidants; beta Carotene; Cause of Death; Dietary Supplements; Follow-Up Studies; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Risk; Smoking | 2003 |
Manganese superoxide dismutase (MnSOD) polymorphism, alpha-tocopherol supplementation and prostate cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study (Finland).
Topics: Aged; alpha-Tocopherol; Antioxidants; beta Carotene; Case-Control Studies; Finland; Genotype; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Superoxide Dismutase | 2003 |
Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
Topics: Age Distribution; Aged; alpha-Tocopherol; Case-Control Studies; Diet; Fatty Acids; Follow-Up Studies; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Probability; Prostatic Neoplasms; Reference Values; Risk Assessment; Sensitivity and Specificity; Smoking; Surveys and Questionnaires | 2003 |
The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.
Topics: alpha-Tocopherol; Antioxidants; Cell Division; Chromans; Cyclin D1; Dose-Response Relationship, Drug; gamma-Tocopherol; Humans; Male; Propionates; Prostatic Neoplasms | 2004 |
Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
Topics: Aged; alpha-Tocopherol; Antioxidants; Case-Control Studies; Chromatography, High Pressure Liquid; Confidence Intervals; Finland; gamma-Tocopherol; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Risk Factors; Vitamin E | 2005 |
Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Genetic Predisposition to Disease; Humans; Lycopene; Male; Middle Aged; Polymorphism, Genetic; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Superoxide Dismutase | 2005 |
Lycopene intake and prostate cancer risk: effect modification by plasma antioxidants and the XRCC1 genotype.
Topics: Aged; alpha-Tocopherol; Anticarcinogenic Agents; Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Chromatography, High Pressure Liquid; Codon; Confidence Intervals; DNA-Binding Proteins; Genotype; Humans; Lycopene; Male; Middle Aged; North Carolina; Odds Ratio; Polymorphism, Restriction Fragment Length; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires; X-ray Repair Cross Complementing Protein 1 | 2006 |
Dietary factors of one-carbon metabolism and prostate cancer risk.
Topics: Aged; Alcohol Drinking; alpha-Tocopherol; beta Carotene; Carbon; Case-Control Studies; Dietary Supplements; Double-Blind Method; Ethanol; Finland; Folic Acid; Humans; Male; Methionine; Middle Aged; One-Carbon Group Transferases; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Smoking; Vitamin B 12; Vitamin B 6 | 2006 |
A prospective investigation of height and prostate cancer risk.
Topics: Aged; alpha-Tocopherol; beta Carotene; Body Height; Cohort Studies; Follow-Up Studies; Growth Hormone; Humans; Male; Middle Aged; Neoplasm Metastasis; Proportional Hazards Models; Prospective Studies; Prostatic Neoplasms; Risk Factors | 2006 |
Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
Topics: alpha-Tocopherol; Biological Availability; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Gene Expression; Humans; Male; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tocopherols; Vitamin E | 2007 |
Validation of a food frequency questionnaire measurement of selected nutrients using biological markers in African-American men.
Topics: Adipose Tissue; alpha-Tocopherol; Biomarkers; Black or African American; Carotenoids; Cohort Studies; Diet; Energy Intake; Humans; Male; Middle Aged; Nutrition Surveys; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Statistics, Nonparametric; Surveys and Questionnaires | 2007 |
Advanced but not localized prostate cancer is associated with increased oxidative stress.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Androgen Antagonists; Biopsy; Bone Neoplasms; Cohort Studies; Disease Progression; Humans; Lipid Peroxidation; Lymphatic Metastasis; Male; Malondialdehyde; Middle Aged; Neoplasm Staging; Oxidative Stress; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Reference Values; Risk Factors; Uric Acid | 2007 |
Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
Topics: Adaptor Proteins, Signal Transducing; alpha-Tocopherol; Apoptosis; Caspase 8; Cell Line, Tumor; Co-Repressor Proteins; Fas Ligand Protein; fas Receptor; Fas-Associated Death Domain Protein; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mitochondria; Molecular Chaperones; Nuclear Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-jun; Signal Transduction; Up-Regulation; Vitamin E; Vitamins | 2008 |
The relationship between reduced vitamin antioxidant concentrations and the systemic inflammatory response in patients with common solid tumours.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Antioxidants; Body Mass Index; Breast Neoplasms; C-Reactive Protein; Carotenoids; Colorectal Neoplasms; Female; Humans; Inflammation; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Vitamin A; Vitamins | 2002 |
δ-Tocotrienol is the Most Potent Vitamin E Form in Inhibiting Prostate Cancer Cell Growth and Inhibits Prostate Carcinogenesis in Ptenp-/- Mice.
Topics: Animals; Cell Transformation, Neoplastic; Humans; Male; Mice; Prostate; Prostatic Neoplasms; Vitamin E | 2022 |
Exploiting the Metabolic Consequences of PTEN Loss and Akt/Hexokinase 2 Hyperactivation in Prostate Cancer: A New Role for δ-Tocotrienol.
Topics: Cell Line, Tumor; Glycolysis; Hexokinase; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Vitamin E | 2022 |
Co-carcinogenic effects of vitamin E in prostate.
Topics: 3T3 Cells; Animals; Benzo(a)pyrene; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cytochrome P-450 Enzyme System; Dietary Supplements; DNA Damage; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lipid Peroxidation; Male; Mice; Micronuclei, Chromosome-Defective; Neoplasms, Experimental; Oxidative Stress; Prostate; Prostatic Neoplasms; Rats; Reactive Oxygen Species; Up-Regulation; Vitamin E | 2019 |
Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Humans; Male; Mitochondria; Prostatic Neoplasms; Reactive Oxygen Species; Vitamin E | 2020 |
Organoids model distinct Vitamin E effects at different stages of prostate cancer evolution.
Topics: Antioxidants; Cell Proliferation; Cells, Cultured; Computational Biology; High-Throughput Nucleotide Sequencing; Humans; Male; Microarray Analysis; Organoids; Oxygen Consumption; Prostatic Neoplasms; Reactive Oxygen Species; Tissue Culture Techniques; Vitamin E | 2017 |
Combination Effect of δ-Tocotrienol and γ-Tocopherol on Prostate Cancer Cell Growth.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Bixaceae; Carotenoids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; G1 Phase; G2 Phase; Humans; Male; Osmolar Concentration; Plant Extracts; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Vitamin E | 2017 |
The use of polysulfated polysaccharides heparin like compounds, glycosaminoglycans and Vitamin B17 as a possible treatment for prostate cancer.
Topics: Adenocarcinoma; Amygdalin; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Combinations; Drug Synergism; Extracellular Matrix; Glycosaminoglycans; Heparitin Sulfate; Humans; Injections, Intravenous; Male; Models, Biological; Myocytes, Smooth Muscle; Polysaccharides; Prostate; Prostatic Neoplasms; Vitamin A; Vitamin E | 2018 |
Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.
Topics: Adaptation, Physiological; Animals; Cell Hypoxia; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Male; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Prostatic Neoplasms; SOXB1 Transcription Factors; Tumor Cells, Cultured; Vitamin E; Vitamins; Xenograft Model Antitumor Assays | 2018 |
Tardive Dyskinesia: Is Vitamin E Singing the Prostate Blues?
Topics: Antioxidants; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Schizophrenia; Tardive Dyskinesia; Vitamin E | 2018 |
Uncommon presentation of medication-related osteonecrosis of the mandible in a patient with metastatic prostate cancer.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bone Density Conservation Agents; Free Radical Scavengers; Humans; Male; Mandible; Osteonecrosis; Pentoxifylline; Prostatic Neoplasms; Vitamin E; Zoledronic Acid | 2019 |
Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway.
Topics: Angiopoietin-1; Autophagy; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromans; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Male; Prostatic Neoplasms; Receptor, TIE-2; Signal Transduction; Vitamin E | 2019 |
Anionic and Cationic Vitamin E-TPGS Mixed Polymeric Phospholipid Micellar Vehicles.
Topics: Antineoplastic Agents; Berberine; Cell Line, Tumor; Drug Delivery Systems; Humans; Hydrophobic and Hydrophilic Interactions; Male; Micelles; Nanoparticles; Nanostructures; Phospholipids; Prostatic Neoplasms; Solubility; Vitamin E | 2019 |
Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
Topics: Brachytherapy; Catheters; Cobalt; Copper Sulfate; Feasibility Studies; Female; Fiducial Markers; Fish Oils; Humans; Iothalamate Meglumine; Magnetic Resonance Imaging, Interventional; Male; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Sepharose; Sodium Chloride; Titanium; Tomography, X-Ray Computed; Uncertainty; Uterine Cervical Neoplasms; Vitamin E | 2013 |
Phase III prostate cancer chemoprevention trials.
Topics: 5-alpha Reductase Inhibitors; Antioxidants; Chemoprevention; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenomethionine; Treatment Outcome; Vitamin E | 2014 |
Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk.
Topics: Aged; Antioxidants; Black or African American; Canada; Cohort Studies; Dietary Supplements; Humans; Male; Middle Aged; Nails; Neoplasm Grading; Odds Ratio; Proportional Hazards Models; Prostatic Neoplasms; Puerto Rico; Randomized Controlled Trials as Topic; Risk; Selenium; Trace Elements; United States; Vitamin E; Vitamins | 2014 |
Baseline selenium and prostate cancer risk: comments and open questions.
Topics: Antioxidants; Black or African American; Dietary Supplements; Humans; Male; Nails; Prostatic Neoplasms; Selenium; Vitamin E | 2014 |
Prostate cancer: new data on risks of selenium and vitamin E.
Topics: Antioxidants; Black or African American; Dietary Supplements; Humans; Male; Nails; Prostatic Neoplasms; Selenium; Selenoproteins; Vitamin E | 2014 |
Nanoparticles of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Humans; Male; Nanoparticles; Paclitaxel; Polyesters; Prostatic Neoplasms; Proton Magnetic Resonance Spectroscopy; Vitamin E | 2014 |
[High doses of selenium and vitamin E administration increased risk of cancer].
Topics: Humans; Male; Neoplasms; Prostatic Neoplasms; Risk; Selenium; Vitamin E; Vitamins | 2014 |
Selenium and vitamin E raise risk of prostate cancer.
Topics: Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E; Vitamins | 2014 |
Polysaccharopeptide enhanced the anti-cancer effect of gamma-tocotrienol through activation of AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Cell Line; Chromans; Drug Synergism; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Proteoglycans; Vitamin E | 2014 |
On call. In the May 2014 issue, you reported on findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT), which said that taking vitamin E and selenium raises the risk of prostate cancer. My multivitamin contains both of these nutrients
Topics: Antioxidants; Dietary Supplements; Health Behavior; Humans; Male; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2014 |
Biological activities and chemical content of Sung Yod rice bran oil extracted by expression and soxhlet extraction methods.
Topics: Animals; Antioxidants; Breast Neoplasms; Cell Line; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; HeLa Cells; Humans; Lung Neoplasms; Macrophages; Male; Mice; Neoplasms; Nitric Oxide; Oryza; Phenols; Phenylpropionates; Plant Extracts; Plant Oils; Prostatic Neoplasms; Rice Bran Oil; Thailand; Uterine Cervical Neoplasms; Vitamin E | 2014 |
JNCI and cancer prevention.
Topics: Biomedical Research; Breast Neoplasms; Chemoprevention; Female; Food; Humans; Male; National Cancer Institute (U.S.); Neoplasms; Primary Prevention; Prostatic Neoplasms; Public Health; Secondary Prevention; Selenium; Smoking Cessation; United States; Vitamin E | 2015 |
Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Docetaxel; Human Umbilical Vein Endothelial Cells; Humans; Integrins; Male; Micelles; Nanostructures; Neovascularization, Pathologic; Peptides, Cyclic; Polyethylene Glycols; Prostatic Neoplasms; Receptors, Cell Surface; Taxoids; Vitamin E | 2015 |
The androgen receptor plays a suppressive role in epithelial- mesenchymal transition of human prostate cancer stem progenitor cells.
Topics: Azacitidine; Cell Line, Tumor; Cell Self Renewal; Chromans; Chromones; Decitabine; Drug Synergism; Epithelial-Mesenchymal Transition; Humans; Male; Morpholines; Neoplastic Stem Cells; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Vitamin E | 2015 |
Targeted Reduction in Body Mass Index Is a Worthwhile Risk Reduction Strategy for Prostate Cancer.
Topics: Anticarcinogenic Agents; Black or African American; Health Status Disparities; Humans; Male; Obesity; Prostatic Neoplasms; Vitamin E; White People | 2015 |
Annatto Tocotrienol Induces a Cytotoxic Effect on Human Prostate Cancer PC3 Cells via the Simultaneous Inhibition of Src and Stat3.
Topics: Antineoplastic Agents; Apoptosis; Bixaceae; Carotenoids; Cell Cycle; Cell Line, Tumor; Genes, src; Humans; Male; Plant Extracts; Prostatic Neoplasms; STAT3 Transcription Factor; Tocotrienols; Vitamin E; Vitamins | 2015 |
Re: Difference in Association of Obesity with Prostate Cancer Risk between US African American and Non-Hispanic White Men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Anticarcinogenic Agents; Black or African American; Health Status Disparities; Humans; Male; Obesity; Prostatic Neoplasms; Vitamin E; White People | 2016 |
Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.
Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dietary Supplements; Early Detection of Cancer; Finland; Follow-Up Studies; Humans; Male; Prostatic Neoplasms; Puberty; Risk Assessment; Risk Factors; Selenium; Ubiquinone; Vitamin D; Vitamin E; Vitamins; Zinc | 2016 |
Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Cell Line, Tumor; Chemistry, Pharmaceutical; Docetaxel; Female; Half-Life; Humans; Inhibitory Concentration 50; Liposomes; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prodrugs; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Taxoids; Vitamin E; Xenograft Model Antitumor Assays | 2016 |
Is There a Future for Chemoprevention of Prostate Cancer?
Topics: Anticarcinogenic Agents; Biomarkers; Chemoprevention; Clinical Trials, Phase II as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2016 |
Vitamins, metabolomics, and prostate cancer.
Topics: Adult; Age Factors; Aged; Case-Control Studies; Humans; Incidence; Male; Metabolomics; Micronutrients; Middle Aged; Primary Prevention; Prognosis; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Vitamin A; Vitamin D; Vitamin E; Vitamins | 2017 |
Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Synergism; Humans; Male; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Selenium; Up-Regulation; Vitamin E | 2008 |
Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil in vitro.
Topics: Animals; Carotenoids; Cattle; Cell Line, Tumor; Cell Survival; Culture Media; Depression, Chemical; Epithelial Cells; Fetal Blood; Fish Oils; Humans; Integrin alpha2beta1; Integrin alphaVbeta3; Integrins; Lycopene; Male; Prostate; Prostatic Neoplasms; Receptors, Vitronectin; Vitamin E | 2009 |
Vitamin E and prostate cancer: where do we stand?
Topics: Antioxidants; Humans; Male; Prostatic Neoplasms; Vitamin E | 2006 |
Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromans; Flow Cytometry; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Signal Transduction; Vitamin E | 2008 |
Randomized trials of antioxidant supplementation for cancer prevention: first bias, now chance--next, cause.
Topics: Antioxidants; Ascorbic Acid; Dietary Supplements; Humans; Male; Neoplasms; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study.
Topics: Adult; Aged; beta Carotene; Case-Control Studies; Dietary Supplements; Folic Acid; Humans; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Vitamin E; Vitamins; Zinc | 2009 |
Vitamin supplements and cancer prevention: where do randomized controlled trials stand?
Topics: Antioxidants; Ascorbic Acid; beta Carotene; Colorectal Neoplasms; Confounding Factors, Epidemiologic; Dietary Supplements; Female; Folic Acid; Humans; Incidence; Lung Neoplasms; Male; Neoplasms; Primary Prevention; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Selenium; United States; Vitamin B 12; Vitamin B 6; Vitamin E | 2009 |
Nitric oxide synthase gene polymorphisms and prostate cancer risk.
Topics: Aged; Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Genotype; Humans; Lycopene; Male; Middle Aged; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Prostatic Neoplasms; Risk Factors; Vitamin E | 2009 |
Selenium for prostate cancer prevention.
Topics: Antioxidants; Ascorbic Acid; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Lifestyle factors for longer life.
Topics: Antioxidants; Ascorbic Acid; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Vitamins E and C in the prevention of cardiovascular disease and cancer in men.
Topics: Aged; Ascorbic Acid; Cardiovascular Diseases; Clinical Protocols; Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Male; Middle Aged; Neoplasms; Oxidative Stress; Patient Compliance; Prostatic Neoplasms; Vitamin E | 2009 |
The Outcome of Selenium and Vitamin E Cancer Prevention Trial (SELECT) reveals the need for better understanding of selenium biology.
Topics: Animals; Black or African American; Chemoprevention; Dietary Supplements; Double-Blind Method; Humans; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Selenoproteins; Treatment Outcome; Vitamin E | 2009 |
On call. I have been taking selenium in the hope that it would prevent me from getting prostate cancer. But I heard on the radio that the National Cancer Institute is advising men to stop taking selenium. Should I stop it?
Topics: Antioxidants; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
StatBite: Physicians' Health Study II randomized controlled trial results.
Topics: Aged; Anticarcinogenic Agents; Ascorbic Acid; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Dietary Supplements; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Neoplasms; Physicians; Prostatic Neoplasms; Randomized Controlled Trials as Topic; United States; Vitamin E | 2009 |
Prostate cancer: neither vitamin E nor selenium prevents prostate cancer.
Topics: Dietary Supplements; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2009 |
A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model.
Topics: Animals; Apoptosis; Blotting, Western; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Transgenic; Micronutrients; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Selenium and vitamin E supplementation for cancer prevention.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Selenomethionine; Vitamin E | 2009 |
Selenium and vitamin E supplementation for cancer prevention.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Selenomethionine; Vitamin E | 2009 |
Antioxidant supplementation and cancer prevention.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Survival Analysis; Vitamin E | 2009 |
Dietary vitamins E and C and prostate cancer risk.
Topics: Aged; Antioxidants; Ascorbic Acid; Case-Control Studies; Diet; Humans; Incidence; Italy; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; Vitamin E | 2009 |
RE: Lessons from the selenium and vitamin E cancer prevention trial (SELECT).
Topics: Antioxidants; Clinical Trials as Topic; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2009 |
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
Topics: Age Distribution; Aged; Aged, 80 and over; Cross-Sectional Studies; Dietary Supplements; Genetic Variation; Humans; Incidence; Male; Middle Aged; Primary Prevention; Prognosis; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Assessment; Selenium; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Vitamin E | 2009 |
Comment re: Vitamin E transport gene variants and prostate cancer.
Topics: Biological Transport; Carrier Proteins; Genetic Linkage; Genetic Variation; Humans; Lipoproteins; Male; Prostatic Neoplasms; Trans-Activators; Vitamin E | 2009 |
Re: Selenium and vitamin E: interesting biology and dashed hope.
Topics: Animals; Anticarcinogenic Agents; Humans; Male; Meta-Analysis as Topic; Prostatic Neoplasms; Selenium; Selenocysteine; Selenomethionine; Vitamin E | 2009 |
Changes in antioxidant status and lipid peroxidation in Nigerian patients with prostate carcinoma.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Case-Control Studies; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Nigeria; Oxidative Stress; Prostatic Neoplasms; Reference Values; Severity of Illness Index; Vitamin E | 2009 |
Id1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells.
Topics: Androgens; Breast Neoplasms; Cell Death; Cell Differentiation; Cell Division; Chromans; Collagen; DNA Fragmentation; Down-Regulation; Drug Combinations; Estrogens; Female; Humans; In Situ Nick-End Labeling; Inhibitor of Differentiation Protein 1; Laminin; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured; Vitamin E | 2010 |
Induction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivatives.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bixaceae; Carotenoids; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Inhibitory Concentration 50; Isomerism; Male; Palm Oil; Plant Extracts; Plant Oils; Prostatic Neoplasms; Receptors, Androgen; Time Factors; Vitamin E | 2009 |
Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial.
Topics: Antioxidants; Black or African American; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Patient Selection; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Support as Topic; Selenium; United States; Vitamin E | 2010 |
Serum micronutrient and antioxidant levels at baseline and the natural history of men with localised prostate cancer on active surveillance.
Topics: Aged; Antioxidants; beta Carotene; Carotenoids; Humans; Lycopene; Male; Micronutrients; Middle Aged; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Vitamin E | 2010 |
In vivo evidence of gamma-tocotrienol as a chemosensitizer in the treatment of hormone-refractory prostate cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cadherins; Cell Line, Tumor; Cell Proliferation; Chromans; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Prostatic Neoplasms; Tissue Distribution; Vitamin E | 2010 |
[Selenium in complementary oncology. A critical comments on the SELECT trial].
Topics: Antioxidants; Clinical Trials, Phase III as Topic; Humans; Male; Prostatic Neoplasms; Selenium; Selenium Compounds; Vitamin E | 2010 |
Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.
Topics: Androgens; Animals; Carotenoids; Cell Proliferation; Cysteine; Lycopene; Male; Neoplasm Transplantation; Organoselenium Compounds; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Tumor Burden; Vitamin E | 2010 |
Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA).
Topics: Antioxidants; Breast Neoplasms; Cell Line, Tumor; Chromatography, Liquid; Colonic Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Mass Spectrometry; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species; Vitamin E; Vorinostat | 2011 |
Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.
Topics: Angiogenesis Inhibitors; Animals; Anticarcinogenic Agents; Blood Platelets; Carotenoids; Dietary Supplements; Disease Progression; Immunohistochemistry; Lycopene; Male; Mice; Mice, Transgenic; Micronutrients; Neovascularization, Pathologic; Platelet Adhesiveness; Platelet Factor 4; Prostatic Neoplasms; Proteomics; Selenium; Time Factors; Tumor Burden; Up-Regulation; Vitamin E | 2010 |
Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Chromans; Humans; Male; Mice; Mice, Nude; Neoplastic Stem Cells; Prostatic Neoplasms; Vitamin E; Xenograft Model Antitumor Assays | 2011 |
Chemoprevention of prostate cancer with lycopene in the TRAMP model.
Topics: Animal Feed; Animals; Anticarcinogenic Agents; Carotenoids; Diet; Disease Models, Animal; DNA Damage; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Lycopene; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Organ Size; Prostate; Prostatic Neoplasms; Random Allocation; Vitamin E; Vitamins | 2010 |
Trace elements and vitamin E status in Nigerian patients with prostate cancer.
Topics: Adult; Aged; Case-Control Studies; Copper; Humans; Lipid Peroxidation; Luminescent Measurements; Male; Middle Aged; Nigeria; Nutritional Status; Prostate-Specific Antigen; Prostatic Neoplasms; Superoxide Dismutase; Trace Elements; Vitamin E; Young Adult; Zinc | 2010 |
Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trial.
Topics: Antioxidants; Humans; Male; Middle Aged; Patient Selection; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2010 |
Validation of a quantitative FFQ for the Barbados National Cancer Study.
Topics: Adult; Aged; Aged, 80 and over; Barbados; Black People; Breast Neoplasms; Case-Control Studies; Cross-Sectional Studies; Diet; Diet Records; Diet Surveys; Dietary Fiber; Evaluation Studies as Topic; Feeding Behavior; Female; Folic Acid; Humans; Male; Middle Aged; Nutrition Assessment; Prostatic Neoplasms; Surveys and Questionnaires; Vitamin A; Vitamin B 12; Vitamin E; Vitamins | 2011 |
γ-Tocotrienol induces growth arrest through a novel pathway with TGFβ2 in prostate cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Chromans; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Prostatic Neoplasms; Structure-Activity Relationship; Transforming Growth Factor beta2; Tumor Cells, Cultured; Vitamin E | 2011 |
Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; Ceramides; Chromans; Humans; Intracellular Space; Male; Mevalonic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Sphingosine; Tumor Burden; Vitamin E | 2012 |
Use of a food frequency questionnaire to assess diets of Jamaican adults: validation and correlation with biomarkers.
Topics: Adult; Aged; Biomarkers; Calibration; Case-Control Studies; Cholesterol; Diet; Dietary Fats; Dietary Proteins; Energy Intake; Feeding Behavior; Female; Folic Acid; Humans; Jamaica; Male; Middle Aged; Prostatic Neoplasms; Regression Analysis; Reproducibility of Results; Surveys and Questionnaires; Vitamin A; Vitamin E | 2011 |
Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Ascorbic Acid; Bone Neoplasms; Catalase; Cyproterone Acetate; Erythrocytes; Goserelin; Humans; Lipid Peroxidation; Male; Middle Aged; Neoplasm Grading; Oxidative Stress; Prostatic Neoplasms; Protein Carbonylation; Sulfhydryl Compounds; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2011 |
Vitamin E and prostate cancer: research focus turns to biologic mechanisms.
Topics: Antioxidants; Humans; Male; Nutrition Surveys; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Smoking; United States; Vitamin E | 2011 |
Reducing prostate cancer risk: good news, bad news, or no new news?
Topics: Antioxidants; Diet; Health Behavior; Health Promotion; Humans; Life Style; Male; Men's Health; Prostatic Neoplasms; Vitamin E | 2011 |
Induction of DNA damage and caspase-independent programmed cell death by vitamin E.
Topics: Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; DNA Damage; Drug Screening Assays, Antitumor; Etoposide; Humans; Isomerism; Male; Poly(ADP-ribose) Polymerases; Polyethylene Glycols; Prostatic Neoplasms; Tocotrienols; Vitamin E | 2012 |
Heart healthy=prostate healthy: SELECT, the symbolic end of preventing prostate cancer via heart unhealthy and over anti-oxidation mechanisms?
Topics: Antioxidants; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Follow-Up Studies; Heart; Humans; Male; Prostate; Prostatic Neoplasms; Risk Factors; Selenium; Skin Neoplasms; Vitamin E | 2012 |
Long-term study finds vitamin E supplements raise the risk of prostate cancer.
Topics: Clinical Trials as Topic; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Risk; Vitamin E | 2011 |
Prostate cancer risk and vitamin E.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2012 |
Prostate cancer risk and vitamin E.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2012 |
A key regulator of cholesterol homoeostasis, SREBP-2, can be targeted in prostate cancer cells with natural products.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; CHO Cells; Cholesterol; Chromans; Cricetinae; Cricetulus; Humans; Intracellular Signaling Peptides and Proteins; Liver X Receptors; Male; Membrane Proteins; Mutant Proteins; Neoplasm Proteins; Orphan Nuclear Receptors; Prostatic Neoplasms; Recombinant Proteins; Sterol Regulatory Element Binding Protein 2; Tocotrienols; Triterpenes; Vitamin E | 2012 |
Vitamin E and prostate cancer.
Topics: Humans; Male; Prostatic Neoplasms; Vitamin E | 2012 |
Vitamin E and prostate cancer.
Topics: Antioxidants; Dietary Supplements; Humans; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2012 |
Prevalence and predictors of selenium and vitamin E supplementation in a urology population.
Topics: Adult; Antioxidants; Dietary Supplements; Educational Status; Health Literacy; Humans; Male; Micronutrients; Multivariate Analysis; Prostatic Neoplasms; Selenium; Surveys and Questionnaires; Urology; Vitamin E | 2013 |
SELECT (opportunity for prostate cancer prevention).
Topics: Clinical Trials as Topic; Diet; Hawaii; Humans; Male; Middle Aged; Primary Prevention; Prostatic Neoplasms; Selenium; Vitamin E | 2002 |
A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands).
Topics: Aged; Alcohol Drinking; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Cohort Studies; Confidence Intervals; Cryptoxanthins; Feeding Behavior; Humans; Male; Middle Aged; Multivariate Analysis; Netherlands; Prospective Studies; Prostatic Neoplasms; Risk Factors; Surveys and Questionnaires; Vitamin A; Vitamin E; Xanthophylls | 2002 |
Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines.
Topics: CDC2-CDC28 Kinases; Cell Cycle Proteins; Cell Division; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Gene Expression Regulation, Neoplastic; Humans; Male; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Tumor Cells, Cultured; Up-Regulation; Vitamin E | 2002 |
Selenium and Vitamin E Cancer Prevention Trial--this one's for us.
Topics: Antioxidants; Black or African American; Humans; Male; Prostatic Neoplasms; Research Design; Selenium; Vitamin E | 2002 |
Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery.
Topics: Anticarcinogenic Agents; Cell Cycle; Cell Cycle Proteins; Cell Division; DNA-Binding Proteins; E2F Transcription Factors; G1 Phase; Humans; Male; Prostatic Neoplasms; Retinoblastoma Protein; RNA, Messenger; Selenomethionine; Tocopherols; Transcription Factors; Tumor Cells, Cultured; Vitamin E | 2003 |
Reactive oxygen species-mediated regulation of eNOS and iNOS expression in multicellular prostate tumor spheroids.
Topics: Antioxidants; Apoptosis; Arginine; Benzoates; Buthionine Sulfoximine; Caspase 3; Caspases; Enzyme Inhibitors; Epidermal Growth Factor; Fluorescein; Free Radical Scavengers; Humans; Hydrogen Peroxide; Imidazoles; Immunoenzyme Techniques; Indicators and Reagents; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prostatic Neoplasms; Reactive Oxygen Species; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured; Vitamin E | 2003 |
Supplements and the prostate: widespread use, little evidence.
Topics: Adult; Aged; Antioxidants; Clinical Trials as Topic; Dietary Supplements; Finasteride; Humans; Male; Middle Aged; Prostatic Neoplasms; Selenium; Sensitivity and Specificity; Vitamin E; Vitamins | 2003 |
The synergistic effect of conventional and sustained delivery of antioxidants on LNCaP prostate cancer cell line.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carotenoids; Cell Count; Dose-Response Relationship, Drug; Humans; Lycopene; Male; Malondialdehyde; Neoplasm Proteins; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Selenium; Sensitivity and Specificity; Tumor Cells, Cultured; Vitamin E | 2003 |
Frequent use of complementary medicine by prostate cancer patients.
Topics: Aged; Aged, 80 and over; Austria; Combined Modality Therapy; Complementary Therapies; Dietary Fats; Follow-Up Studies; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Selenium; Surveys and Questionnaires; Vitamin E | 2003 |
Alcoholic beverage preference and characteristics of drinkers and nondrinkers in western New York (United States).
Topics: Adult; Aged; Alcohol Drinking; Alcoholic Beverages; Beer; Breast Neoplasms; Carotenoids; Case-Control Studies; Diet; Dietary Fats; Dietary Fiber; Edible Grain; Educational Status; Female; Food Preferences; Fruit; Humans; Income; Life Style; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction; New York; Potassium, Dietary; Prostatic Neoplasms; Smoking; Vegetables; Vitamin E; Wine | 2003 |
Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells.
Topics: Androgen Antagonists; Antioxidants; Chromans; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin E | 2003 |
Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study.
Topics: Aged; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Cohort Studies; Cryptoxanthins; Follow-Up Studies; Humans; Lycopene; Male; Middle Aged; Nails; Netherlands; Prospective Studies; Prostatic Neoplasms; Risk Factors; Selenium; Smoking; Surveys and Questionnaires; Vitamin E; Xanthophylls | 2003 |
Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Drug Synergism; Enzyme Activation; Humans; Isoenzymes; Male; Prostatic Neoplasms; Selenium; Vitamin E | 2003 |
Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Complementary Therapies; Health Surveys; Humans; Male; Middle Aged; Ontario; Phytotherapy; Plant Extracts; Prevalence; Prostatic Neoplasms; Random Allocation; Sampling Studies; Selenium; Self-Help Groups; Serenoa; Surveys and Questionnaires; Vitamin E | 2003 |
Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.
Topics: Antioxidants; Cell Cycle; Cell Division; Chemoprevention; Drug Interactions; Flow Cytometry; Humans; Male; Prostatic Neoplasms; Selenium; Tumor Cells, Cultured; Vitamin E | 2004 |
Re: Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Animals; Anticarcinogenic Agents; Antioxidants; DNA Damage; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Rats; Rats, Inbred Strains; Selenium Compounds; Skin Neoplasms; Testicular Neoplasms; Vitamin E | 2004 |
Vitamin E supplements and risk of prostate cancer in U.S. men.
Topics: Aged; Aged, 80 and over; Antioxidants; Cohort Studies; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Prostatic Neoplasms; Risk Factors; Smoking; United States; Vitamin E | 2004 |
Combination therapy with vitamins C plus E inhibits survivin and human prostate cancer cell growth.
Topics: Antioxidants; Apoptosis; Ascorbic Acid; Blotting, Western; Cell Division; Cysteine Proteinase Inhibitors; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Apoptosis Proteins; Male; Microtubule-Associated Proteins; Neoplasm Proteins; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Survivin; Tumor Cells, Cultured; Vitamin E | 2004 |
RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
Topics: Base Sequence; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; DNA Primers; Humans; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Polymerase Chain Reaction; Prostatic Neoplasms; RNA, Neoplasm; Tocopherols; Vitamin E | 2004 |
A case--control study of selenium in nails and prostate cancer risk in British men.
Topics: Aged; Case-Control Studies; Dietary Supplements; Humans; Male; Middle Aged; Nails; Prostatic Neoplasms; Risk; Selenium; Smoking; United Kingdom; Vitamin E | 2004 |
Re: Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets.
Topics: Animals; Anticarcinogenic Agents; Caloric Restriction; Carotenoids; Disease Models, Animal; Drug Synergism; Lycopene; Male; Methylnitrosourea; Mice; Powders; Prostatic Neoplasms; Rats; Solanum lycopersicum; Testosterone; Vitamin E | 2004 |
Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model.
Topics: Androgens; Animals; Autocrine Communication; Body Weight; Carotenoids; Cholestenone 5 alpha-Reductase; Diet; Dietary Supplements; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Insulin-Like Growth Factor I; Lycopene; Magnetic Resonance Imaging; Male; Necrosis; Oligonucleotide Array Sequence Analysis; Paracrine Communication; Prostatic Neoplasms; Rats; RNA, Messenger; RNA, Neoplasm; Vitamin E | 2004 |
Diet and prostate cancer.
Topics: Diet; Dietary Fats; Humans; Male; Phytosterols; Prostatic Neoplasms; Risk Factors; Trace Elements; Vitamin E | 2004 |
Antioxidants block prostate cancer in lady transgenic mice.
Topics: Animals; Antigens, Viral, Tumor; Antioxidants; Carotenoids; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Diet; Female; Immunohistochemistry; Lycopene; Male; Mice; Mice, Transgenic; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Selenium; Testosterone; Tumor Suppressor Proteins; Vitamin E | 2004 |
The effect of prostate cancer and antiandrogenic therapy on lipid peroxidation and antioxidant systems.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antioxidants; Erythrocytes; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Goserelin; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Prostatic Neoplasms; Vitamin E | 2004 |
Inhibition of prostate cancer cell growth by an avocado extract: role of lipid-soluble bioactive substances.
Topics: Blotting, Western; Carotenoids; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Lipids; Lutein; Male; Persea; Plant Extracts; Prostatic Neoplasms; Solubility; Vitamin E | 2005 |
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Canada; Clinical Trials, Phase III as Topic; Humans; Male; Middle Aged; Multicenter Studies as Topic; Patient Selection; Prostatic Neoplasms; Puerto Rico; Randomized Controlled Trials as Topic; Research Design; Selenium; United States; Vitamin E | 2005 |
Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cells.
Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mitochondria; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Tocopherols; Vitamin E | 2005 |
Gamma-tocotrienol metabolism and antiproliferative effect in prostate cancer cells.
Topics: Cell Division; Chromans; Humans; Ketoconazole; Male; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin E | 2004 |
Centralized blood processing for the selenium and vitamin E cancer prevention trial: effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones, and lymphocyte vi
Topics: Adult; Antioxidants; Biomarkers; Blood Chemical Analysis; Cell Survival; Endpoint Determination; Humans; Lymphocytes; Male; Middle Aged; Prostatic Neoplasms; Selenium; Specimen Handling; Time Factors; Vitamin E | 2005 |
Vitamin E from select plant seeds could inhibit lung and prostate cancer growth.
Topics: Carya; Humans; Juglans; Lung Neoplasms; Male; Prostatic Neoplasms; Sesamum; Vitamin E | 2005 |
Clinical trials point to complexities of chemoprevention for cancer.
Topics: Aspirin; Breast Neoplasms; Clinical Trials as Topic; Diet; Dihydrotestosterone; Female; Finasteride; Humans; Male; Neoplasms; Prostatic Neoplasms; Selective Estrogen Receptor Modulators; Tamoxifen; Vitamin E | 2005 |
Reactive oxygen species-linked regulation of the multidrug resistance transporter P-glycoprotein in Nox-1 overexpressing prostate tumor spheroids.
Topics: Ascorbic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Line, Tumor; Drug Resistance, Multiple; Free Radical Scavengers; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Multidrug Resistance-Associated Proteins; NADPH Oxidase 1; NADPH Oxidases; Onium Compounds; Prostatic Neoplasms; Reactive Oxygen Species; Spheroids, Cellular; Sulfones; Transcription Factors; Vitamin E | 2005 |
Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
Topics: Animals; Carrier Proteins; Cell Growth Processes; Cell Line, Tumor; Gene Expression; Humans; Lipoproteins; Male; MAP Kinase Signaling System; Mice; Mice, Nude; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Trans-Activators; Transplantation, Heterologous; Vitamin E | 2005 |
Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Topics: Aged; Antioxidants; Black or African American; Clinical Trials, Phase III as Topic; Humans; Male; Middle Aged; Patient Selection; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Research Design; Vitamin E | 2005 |
Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis.
Topics: Animals; Apoptosis; Caspases; Caspases, Initiator; Cell Proliferation; Gene Expression Profiling; Humans; Male; Mice; Mice, SCID; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Rats; Reverse Transcriptase Polymerase Chain Reaction; Tocopherols; Transplantation, Heterologous; Tumor Cells, Cultured; Vitamin E | 2006 |
Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol.
Topics: Animals; Antioxidants; Chromans; Iron; Kidney; Lipid Peroxidation; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Radiation-Sensitizing Agents; Rectum; Tumor Cells, Cultured; Vitamin E | 2006 |
Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Cobalt; Copper; Humans; Iron; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nickel; Prostatic Neoplasms; Selenium; Trace Elements; Vitamin A; Vitamin E; Zinc | 2006 |
Vitamin E in the prevention of prostate cancer: where are we today?
Topics: Anticarcinogenic Agents; Antioxidants; Dietary Supplements; Humans; Incidence; Male; Mass Screening; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Risk Assessment; Smoking; Treatment Outcome; Vitamin E | 2006 |
Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
Topics: Adult; Aged; Anticarcinogenic Agents; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Humans; Incidence; Male; Mass Screening; Middle Aged; Prospective Studies; Prostatic Neoplasms; Risk Assessment; Smoking; Treatment Outcome; United States; Vitamin E | 2006 |
alpha-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function.
Topics: Apoptosis; bcl-X Protein; Cell Proliferation; Cytochromes c; Humans; Male; Models, Molecular; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering; Tocopherols; Tumor Cells, Cultured; Vitamin E | 2006 |
Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice.
Topics: Animals; Anticarcinogenic Agents; Carotenoids; Cell Division; Cell Line, Tumor; Cell Survival; Dietary Supplements; Humans; Lycopene; Male; Mice; Mice, Nude; Prostatic Neoplasms; Transplantation, Heterologous; Vitamin E | 2006 |
Augmented suppression of androgen receptor signaling by a combination of alpha-tocopheryl succinate and methylseleninic acid.
Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Down-Regulation; Drug Synergism; Humans; Male; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Signal Transduction; Tocopherols; Vitamin E | 2006 |
Alpha-tocopheryl succinate (alpha-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil.
Topics: Animals; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Prostate-Specific Antigen; Prostatic Neoplasms; Soybean Oil; Testosterone; Tocopherols; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vitamin E | 2007 |
Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Cell Survival; Cells, Cultured; Fibroblasts; Humans; Kinetics; Male; Prostate; Prostatic Neoplasms; Vitamin E | 2007 |
Serum selenium and risk of prostate cancer-a nested case-control study.
Topics: Aged; Antioxidants; Case-Control Studies; Confidence Intervals; Humans; Male; Micronutrients; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk Factors; Selenium; Smoking; Vitamin E; Vitamins | 2007 |
Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Adhesion; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; NF-kappa B; Phenotype; Prostatic Neoplasms; Tocopherols; Transcription Factor AP-1; Vitamin E | 2007 |
The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Insulin-Like Growth Factor Binding Protein 3; Male; Mice; Mice, Nude; Mice, Transgenic; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Tocopherols; Vitamin E | 2007 |
Supplemental and dietary vitamin E intakes and risk of prostate cancer in a large prospective study.
Topics: Aged; Diet; Dietary Supplements; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Protein Isoforms; Risk Factors; Surveys and Questionnaires; Vitamin E | 2007 |
Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Topics: Aged; Cohort Studies; Dietary Supplements; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk Factors; SEER Program; Selenium; Vitamin E; Vitamins | 2008 |
Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism.
Topics: 3' Untranslated Regions; Antioxidants; Apoptosis; Blotting, Northern; Blotting, Western; Cell Nucleus; Cell Proliferation; Cytokines; Fluorescent Antibody Technique; Genes, jun; Growth Differentiation Factor 15; Humans; Luciferases; Male; MAP Kinase Kinase 6; MAP Kinase Kinase Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Kinase C; Protein Transport; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Vitamin E | 2008 |
Vitamin E analog alpha-TEA, methylseleninic acid, and trans-resveratrol in combination synergistically inhibit human breast cancer cell growth.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Caspases; Cell Division; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Male; Organoselenium Compounds; Prostatic Neoplasms; Resveratrol; Stilbenes; Tocopherols; Vitamin E | 2008 |
[Spontaneous recovery from metastatic cancer of the kidney. Favourable role of Vitamin E?].
Topics: Abdominal Neoplasms; Adenoma; Aged; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Male; Neoplasms, Second Primary; Nephrectomy; Prostatectomy; Prostatic Neoplasms; Remission, Spontaneous; Skin Neoplasms; Urinary Incontinence, Stress; Vitamin E | 1993 |
RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways.
Topics: Adenocarcinoma; Antineoplastic Agents; Cell Differentiation; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Male; Prostatic Neoplasms; Time Factors; Tocopherols; Transforming Growth Factor beta; Tumor Cells, Cultured; Vitamin E | 1995 |
Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study.
Topics: Adult; Aged; Antioxidants; Ascorbic Acid; Carotenoids; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Prostatic Neoplasms; Vitamin A; Vitamin E; Vitamins | 1996 |
dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells.
Topics: Apoptosis; Breast Neoplasms; Cell Division; DNA; DNA Fragmentation; Electrophoresis, Agar Gel; Humans; Leukemia, Erythroblastic, Acute; Male; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin E | 1997 |
Serum micronutrients and prostate cancer in Japanese Americans in Hawaii.
Topics: Aged; Asian; Carotenoids; Causality; Cohort Studies; Cross-Sectional Studies; Feeding Behavior; Follow-Up Studies; Hawaii; Humans; Incidence; Male; Micronutrients; Middle Aged; Odds Ratio; Population Surveillance; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin E | 1997 |
Vitamins A and E: further clues for prostate cancer prevention.
Topics: Anticarcinogenic Agents; beta Carotene; Carotenoids; Cell Transformation, Neoplastic; Humans; Lycopene; Male; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin E | 1998 |
Vitamin E reduces prostate cancer rates in Finnish trial: U.S. considers follow-up.
Topics: Alcohol Drinking; Anticarcinogenic Agents; Finland; Humans; Male; Prostatic Neoplasms; Smoking; United States; Vitamin E | 1998 |
Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation.
Topics: Cell Division; Cell Line; Enzyme Inhibitors; Gene Expression Regulation; Humans; Immunosorbent Techniques; Isoenzymes; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Phosphorylation; Prostatic Neoplasms; Protein Kinase C; Tropomyosin; Tumor Cells, Cultured; Vitamin E | 1998 |
Antioxidants. Vitamin E may cut prostate cancer risk.
Topics: Humans; Male; Prostatic Neoplasms; Vitamin E | 1998 |
Selenium, vitamin E, and prostate cancer--ready for prime time?
Topics: Black or African American; Humans; Male; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 1998 |
Vitamin E may reduce prostate-cancer incidence.
Topics: Aged; Clinical Trials as Topic; Dietary Supplements; Humans; Male; Middle Aged; Prostatic Neoplasms; Vitamin E | 1998 |
Lycopene in association with alpha-tocopherol inhibits at physiological concentrations proliferation of prostate carcinoma cells.
Topics: Antioxidants; Carcinoma; Carotenoids; Cell Division; Drug Synergism; Humans; Lycopene; Male; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin E | 1998 |
Prostate cancer screening.
Topics: Anticarcinogenic Agents; Antioxidants; beta Carotene; Carotenoids; Diet; Humans; Lycopene; Male; Mass Screening; Nutritional Physiological Phenomena; Prostatic Neoplasms; Selenium; Solanum lycopersicum; Vitamin E | 1999 |
Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective basel study.
Topics: Ascorbic Acid; Carotenoids; Follow-Up Studies; Humans; Male; Prostatic Neoplasms; Risk Factors; Smoking; Survivors; Switzerland; Treatment Outcome; Vitamin A; Vitamin E; Vitamins | 1999 |
Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice.
Topics: Animals; Cell Division; Dietary Fats; Male; Mice; Mice, Nude; Neoplasm Transplantation; Oxidative Stress; Prostatic Neoplasms; Tumor Cells, Cultured; Vitamin E | 1999 |
The dietary antioxidant network and prostate carcinoma.
Topics: Antioxidants; beta Carotene; Carotenoids; Case-Control Studies; Clinical Trials as Topic; Diet; Humans; Lycopene; Male; Phytotherapy; Prostatic Neoplasms; Risk; Selenium; Smoking; Solanum lycopersicum; Vitamin E | 1999 |
Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States.
Topics: Adult; Aged; Cohort Studies; Cross-Sectional Studies; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Risk; Smoking; Survival Rate; United States; Vitamin E | 1999 |
Association between serum alpha-tocopherol and serum androgens and estrogens in older men.
Topics: Aged; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Gonadal Steroid Hormones; Humans; Linear Models; Male; Middle Aged; Prostatic Neoplasms; Radioimmunoassay; Surveys and Questionnaires; Vitamin E | 1999 |
Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake.
Topics: Adenocarcinoma; Aged; Biomarkers; Carotenoids; Chromatography, High Pressure Liquid; Diet Surveys; Humans; Linear Models; Male; Middle Aged; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Statistics, Nonparametric; Vitamin A; Vitamin E | 2000 |
Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis.
Topics: Apoptosis; Blotting, Western; Caspase 3; Caspases; DNA Fragmentation; Epithelial Cells; Fas Ligand Protein; fas Receptor; Humans; Male; Membrane Glycoproteins; Poly(ADP-ribose) Polymerases; Prostate; Prostatic Neoplasms; Signal Transduction; Tocopherols; Vitamin E | 2000 |
Present and future management of prostate cancer.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Biopsy; Case Management; Cause of Death; Cryotherapy; Disease-Free Survival; Forecasting; Genes, bcl-2; Genes, p53; Humans; Male; Mass Screening; Neoplasm Invasiveness; Neoplasm Metastasis; Palpation; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiotherapy; Survival Rate; Treatment Outcome; Vitamin E | 2000 |
Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis.
Topics: Androgens; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Division; Ditiocarb; Drug Interactions; Epithelial Cells; Growth Inhibitors; Humans; Male; Necrosis; Neoplasms, Hormone-Dependent; Proline; Prostatic Neoplasms; Testosterone; Thiocarbamates; Tumor Cells, Cultured; Vitamin E | 2000 |
Chemoprevention: an important treatment option for prostate cancer.
Topics: Aged; Antioxidants; Enzyme Inhibitors; Finasteride; Humans; Incidence; Male; Middle Aged; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; United States; Vitamin E | 2000 |
Gamma-tocopherol: a new player in prostate cancer prevention?
Topics: Case-Control Studies; Humans; Incidence; Male; Prostatic Neoplasms; Risk; Vitamin E | 2000 |
Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.
Topics: Aged; Case-Control Studies; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Prostatic Neoplasms; Risk; Risk Factors; Selenium; Vitamin E | 2000 |
Androgen-induced oxidative stress in human LNCaP prostate cancer cells is associated with multiple mitochondrial modifications.
Topics: Antimycin A; Coloring Agents; DNA; Electron Transport; Fluoresceins; Fluorescent Dyes; Humans; Hydroxyl Radical; Male; Metribolone; Mitochondria; Oxidative Stress; Peroxides; Prostatic Neoplasms; Rotenone; Testosterone Congeners; Tetrazolium Salts; Thiazoles; Time Factors; Tocopherols; Tumor Cells, Cultured; Uncoupling Agents; Vitamin E | 1999 |
Antioxidant dietary supplements: Rationale and current status as chemopreventive agents for prostate cancer.
Topics: Androgens; Anticarcinogenic Agents; Antioxidants; Carotenoids; Dietary Fats; Forecasting; Humans; Lycopene; Male; Oxidative Stress; Prostatic Neoplasms; Reactive Oxygen Species; Selenium; Vitamin E | 2001 |
Vitamin E, cancer, and apoptosis.
Topics: Antioxidants; Apoptosis; Humans; Lung Neoplasms; Male; Prostatic Neoplasms; Smoking; Vitamin E | 2001 |
Enrollment begins for largest-ever prostate cancer prevention trial.
Topics: Canada; Clinical Trials as Topic; Humans; Male; Multicenter Studies as Topic; Prostatic Neoplasms; Puerto Rico; Selenium; United States; Vitamin E | 2001 |
SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.
Topics: Double-Blind Method; Humans; Male; Prospective Studies; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; Vitamin E | 2001 |
Prostate cancer prevention trial launched.
Topics: Dietary Supplements; Humans; Male; National Institutes of Health (U.S.); Prostatic Neoplasms; Randomized Controlled Trials as Topic; Selenium; United States; Vitamin E | 2001 |
Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Coculture Techniques; Fas Ligand Protein; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Immune System; Jurkat Cells; Lung Neoplasms; Male; Membrane Glycoproteins; Ovarian Neoplasms; Prostatic Neoplasms; RNA, Messenger; Tretinoin; Vitamin E | 2001 |
Activation of p90RSK and growth stimulation of multicellular tumor spheroids are dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP.
Topics: Acetylcysteine; Adenosine Triphosphate; Calcium; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Flavonoids; Free Radical Scavengers; Humans; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NADPH Oxidases; Phospholipases A; Phospholipases A2; Phosphorylation; Prostatic Neoplasms; Purinergic Agonists; Reactive Oxygen Species; Receptors, Purinergic; Ribosomal Protein S6 Kinases; Spheroids, Cellular; Thiourea; Tumor Cells, Cultured; Vitamin E | 2001 |
Are there age-dependent effects of diet on prostate cancer risk?
Topics: Adult; Age Factors; Aged; Fatty Acids, Unsaturated; Feeding Behavior; Greece; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk; Solanum lycopersicum; Urban Population; Vitamin E | 2001 |
Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells.
Topics: Androgen Receptor Antagonists; Animals; Antioxidants; Cell Division; Chlorocebus aethiops; COS Cells; Dimerization; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Biosynthesis; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Selenium; Tocopherols; Transcription Factors; Tumor Cells, Cultured; Vitamin E | 2002 |
Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor.
Topics: Antineoplastic Agents; Antioxidants; Cell Division; Endothelial Growth Factors; Humans; Lymphokines; Male; Peptide YY; Prostatic Neoplasms; Receptors, Neuropeptide Y; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Vitamin E | 2002 |
Lack of modification by naturally occurring antioxidants of 3,2'-dimethyl-4-aminobiphenyl-initiated rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Antioxidants; Carcinogens; Catechols; Hydroquinones; Hyperplasia; Hypolipidemic Agents; Intestinal Neoplasms; Liver Neoplasms; Male; Pancreatic Neoplasms; Phenylpropionates; Prostatic Neoplasms; Rats; Rats, Inbred F344; Resorcinols; Selenium; Testicular Neoplasms; Vitamin E | 1991 |
Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer.
Topics: Aged; beta Carotene; Carotenoids; Case-Control Studies; Diet; Humans; Lycopene; Male; Middle Aged; Prostatic Neoplasms; Retinol-Binding Proteins; Risk; Vitamin A; Vitamin E | 1990 |
Serum retinol and prostate cancer.
Topics: Age Factors; Aged; beta Carotene; Carotenoids; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Risk Factors; Vitamin A; Vitamin E | 1988 |
Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the Nb rat model.
Topics: Adenocarcinoma; Animals; Doxorubicin; Drug Therapy, Combination; Male; Neoplasm Metastasis; Prostatic Neoplasms; Rats; Vitamin E | 1988 |
Vitamin E enhances the chemotherapeutic effects of adriamycin on human prostatic carcinoma cells in vitro.
Topics: Adenocarcinoma; Cell Line; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Humans; In Vitro Techniques; Male; Prostatic Neoplasms; Tocopherols; Tumor Stem Cell Assay; Vitamin E | 1986 |
The influence of radiotherapy and chemotherapy on the vitamin status of cancer patients.
Topics: Ascorbic Acid; Calcifediol; Female; Humans; Lymphoma; Male; Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Uterine Neoplasms; Vitamin A; Vitamin B 12; Vitamin E; Vitamins | 1985 |